Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No spec sheets....
Generative AI is experimental. Learn more
Yes, brand can matter when choosing a heat pump. Different brands promote themselves at different levels, and some brands don't offer heat pumps that also heat water. Other brands offer heat pumps with many features, including water heating capabilities.
AirPlus
Best Heat Pump Brands For 2021 - AirPlus
Feb 8, 2021 — Compare Heat Pump Brands The brand matters. Not all heat pumps are created equal. Vet a brand by looking at heat pump online reviews. You'll notice that brands promote themselves at different levels: high-quality, low-cost, etc. There are also exclusions. Some brands do not offer heat pumps that also heat water. Others offer heat pumps with many features, including water heating capabilities. Here's a heat pump comparison chart so you can see heat pump ratings for popular brands.
J&W Heating and Air
Does Brand Name Matter When Buying A Home Air Conditioner?
Mar 17, 2023 — When evaluating options for a purchase of this magnitude, you may wonder if the AC brand name matters when buying a home air conditioner. The short answer is YES! The brand does matter when you purchase a new HVAC system for your home.
When evaluating heat pump brands, you can consider factors like:
Reliability: Some brands that are often considered reliable include Mitsubishi, Lennox, Goodman, Carrier, and Trane
Longevity: Most heat pumps last for 15–20 years, with the most durable brands reaching 25 years or more
Warranty: Some brands offer warranties
Customer satisfaction: Some brands are rated highly for customer satisfaction
You can also consider things like: Efficiency, Climate performance, Noise, Features, and SEER ratings.
You can also check out online reviews to learn more about different brands.
Lightwave has an exclusive patented product, no competition.
They can't announce a deal until the customer announces the product.
This following article was just posted in January. Note the timeline given in the chart. It's industry timing that we are talking about - not Lightwave delays.
Polymer silicon-organic-hybrid (SOH)67,72 and plasmonic-organic-hybrid (POH)69 require poling and hermetic sealing, creating significant challenges to making stable devices. Their high-temperature reliability and reflow compatibility need to be further demonstrated, although recent results are promising72. POH modulators, even though they look attractive in the PPA metrics, further suffer from compatibility with CMOS SOI foundries. Good plasmonic metals (Cu, Ag, Au) are also serious contaminants, and need diffusion barrier layers (e.g., TaN) which are optically very lossy.
Polycrystalline layers of other ferroelectric thin-film materials such as BTO show much larger Pockels coefficient (expressed in pm/V) than LNOI73 and comparable to polymers74, and recent demonstrations of large E/O BW65,75 make them promising. Note that a large Pockels coefficient in the device is important, which requires a good overlap of the electric modulation field and the propagating optical mode49,72. As part of the direct wafer bonding process, BTO thin films are fabricated first using molecular beam epitaxy deposition on donor wafers, and then directly wafer bonded to interlayer dielectric/SiO2 of the planarized acceptor SOI wafer using intermediate alumina layers as an adhesive. BTO also requires poling to compensate for hysteresis from ferroelectric domain switching (albeit only?~?1V DC compared to much larger voltages needed for polymer modulators)65. Sources of propagation loss include scattering from waveguide sidewall roughness and residual oxygen vacancies in the BTO thin film—areas for further improvement. BTO also has a lower refractive index compared to Si (nBTO = 2.38, nSi = 3.47 @ 1550 nm) and a significantly large RF relative permittivity that can increase capacitances and velocity mismatch between the optical and electrical fields.
No spec sheets... EOM.
LWLG Blocks >=1K
see replied to post for earlier data
03/18/24 16:00:00 4.12 4.11 4.13 47,122
03/18/24 15:59:42 4.12 4.11 4.12 4,609
03/18/24 15:50:10 4.11 4.11 4.12 1,500
03/18/24 15:46:02 4.11 4.11 4.12 1,227
03/18/24 15:46:02 4.11 4.10 4.11 2,200
03/18/24 15:46:02 4.1099 4.10 4.11 2,400
03/18/24 15:24:07 4.11 4.11 4.12 1,300
03/18/24 13:30:22 4.1193 4.11 4.12 1,500
03/18/24 13:29:07 4.1199 4.11 4.12 2,500
03/18/24 13:28:15 4.11 4.11 4.12 5,000
03/18/24 13:05:16 4.105 4.10 4.11 1,842
03/18/24 13:05:16 4.10 4.10 4.11 1,000
03/18/24 13:05:16 4.105 4.10 4.11 1,000
03/18/24 12:38:17 4.112 4.11 4.12 2,400
03/18/24 12:32:19 4.10 4.10 4.11 2,600
03/18/24 12:32:09 4.0923 4.09 4.10 2,000
03/18/24 12:32:04 4.10 4.09 4.10 1,171
03/18/24 12:32:04 4.10 4.11 4.12 1,000
03/18/24 12:31:59 4.11 4.11 4.12 2,000
03/18/24 12:20:15 4.11 4.11 4.12 3,800
03/18/24 12:20:15 4.115 4.11 4.12 1,200
03/18/24 12:20:01 4.1101 4.11 4.12 3,900
03/18/24 12:19:53 4.115 4.10 4.11 3,000
03/18/24 12:19:48 4.1011 4.10 4.11 3,000
03/18/24 12:07:24 4.11 4.12 4.13 1,300
03/18/24 12:02:48 4.11 4.10 4.11 2,200
03/18/24 11:54:33 4.125 4.12 4.13 1,000
03/18/24 11:53:20 4.115 4.11 4.12 1,000
03/18/24 11:40:14 4.141 4.14 4.15 3,800
03/18/24 11:38:46 4.1398 4.13 4.14 1,400
03/18/24 11:24:16 4.1301 4.13 4.14 1,000
03/18/24 11:20:08 4.115 4.11 4.12 3,100
03/18/24 11:16:07 4.1194 4.11 4.12 1,000
03/18/24 11:06:19 4.1121 4.11 4.12 4,200
03/18/24 10:46:55 4.1815 4.18 4.19 2,200
03/18/24 10:28:40 4.1525 4.15 4.16 3,000
03/18/24 10:28:07 4.15 4.15 4.16 1,000
03/18/24 10:14:46 4.10 4.09 4.10 1,100
03/18/24 10:14:26 4.10 4.09 4.10 1,400
03/18/24 10:14:26 4.10 4.09 4.10 1,400
03/18/24 10:14:16 4.10 4.09 4.10 1,448
03/18/24 10:14:16 4.10 4.10 4.11 1,300
03/18/24 10:14:16 4.10 4.10 4.11 1,400
03/18/24 10:11:47 4.11 4.10 4.11 1,183
03/18/24 10:07:16 4.1008 4.10 4.11 2,000
03/18/24 10:00:49 4.0901 4.09 4.10 1,000
03/18/24 09:57:17 4.09 4.09 4.10 1,600
03/18/24 09:57:17 4.0923 4.09 4.10 1,600
03/18/24 09:45:23 4.10 4.10 4.11 1,200
03/18/24 09:44:17 4.1008 4.10 4.11 1,000
03/18/24 09:41:58 4.13 4.11 4.12 1,300
03/18/24 09:36:06 4.12 4.15 4.19 2,500
03/18/24 09:36:06 4.151 4.15 4.19 1,300
03/18/24 09:36:06 4.151 4.15 4.19 1,100
03/18/24 09:35:41 4.171 4.17 4.20 5,000
03/18/24 09:35:12 4.1519 4.15 4.18 2,000
03/18/24 09:35:08 4.1501 4.15 4.18 1,000
03/18/24 09:31:16 4.1529 4.11 4.17 2,000
03/18/24 09:31:09 4.15 4.15 4.22 2,900
03/18/24 09:30:00 4.15 4.11 4.26 6,100
The timeline is clear.
Dear Fellow Shareholders,
2023 has been a transformational year for Lightwave Logic, underscored by the first commercial material supply and license agreement for our electro-optic polymer materials and ongoing efforts to build on this commercialization momentum. Throughout the year we focused on industry awareness efforts, evangelizing the benefits of our platform at leading industry events globally. We received the "2023 Most Innovative Product – Hybrid PIC/Optical Integration Platform Award at this year's ECOC Exhibition Industry. We are engaging with a variety of companies to discuss product design, device prototype sampling, and material supply and licensing agreements. Operationally, we completed the expansion of our new laboratory production facilities and added key team members to enable our anticipated growth. Supporting these efforts, we continued to fortify our intellectual property position with new patent issuances and patent applications.
Commercialization of EO Polymer Materials
We signed a four (4) year material supply and license agreement for Perkinamine® in May 2023 with a company designing and providing polymer based photonic devices and photonic integrated circuits (PICs). We believe this agreement demonstrates tangible commercial progress for electro-optic polymers as well as market acceptance. We made significant progress throughout the year, with delivery of material to support our licensee.
Per the terms of the non-exclusive material supply and license agreement, the licensee shall pay Lightwave Logic a running royalty with a minimum royalty paid on an annual basis over the term of the License Agreement. Revenue will be generated from royalties from the licensee's sale of licensed products.
In addition to this first licensee, we continue to receive strong interest from other potential customers in our innovative device platform and licensing our technologies. We are working hard to close additional commercial agreements by year end, but since, these are long deliberate processes, we can't guarantee that we will do so. We are presently working with a wide spectrum of companies including multinational tier-1 corporations which manufacture data communications network equipment. Several tier-1 manufacturers have also requested to meet and test our polymer modulators, while fiber optic transceiver companies have expressed interest in learning how to implement our polymer modulators into their ongoing 800G transceiver development programs. Also of note, we are planning to implement our PIC designs using commercial semiconductor foundries for multi-channel polymer modulator engines, including 4 channel solutions for 800G. We believe these constructive discussions are positioning us to capitalize on our momentum with additional licensees as we continue to build excitement around our technology.
Facility & Team in Place to Support Commercialization
During the year we aligned operations with our commercial business plans with a significant laboratory expansion to support volume scale of our EO chromophore materials and new commercial activity. We completed new laboratory production facilities, expanding the corporate facility in Englewood, Colorado by nearly 10,000 square feet for a total of approximately 23,500 square feet. The renovations and installation of new laboratory and engineering facilities expands the size of our facility by over 65%, enabling commercial device testing and evaluation, product reliability testing, high speed optical characterization, SEM analysis and the expansion of our chemical synthesis production line. The facilities are being utilized to provide Perkinamine® chromophore materials for polymer based photonic devices and PICs, and the multiple requests for our prototypes.
To support our commercialization advancement, we added several new key team members in 2023. At the staff level, these new team members included organic chemists as well as additional photonics design, packaging, reliability engineers, and finance personnel to further enhance our in-house capabilities.
At the Board level, the Board of Directors appointed respected industry executive Laila Partridge to the Board. Laila brings a 30+ year track record of executing transactions in the technology space. Her knowledge of both the fiber optic communications markets as well as non-communications markets (such as artificial intelligence, consumer, display, sensing, medical, biotech, etc.) will help us hone business strategies for growing our electro-optic polymer business.
Fortifying Our Intellectual Property Portfolio
We continued to fortify our intellectual property portfolio in 2023 with two new U.S. patents issued and one patent allowed, and expected to be issued in the near future. In addition, we had a further six patent applications published, outlining new inventions to further improve our technology offering. One notable patent issuance was for continued advanced chemical structural design and process that enhances the overall efficiency of poling non-linear organic optical chromophores while simultaneously improving thermal and photostability above what is already an acceptable performance. Finally, we received a patent for a cutting-edge design technique, enhancing the performance of polymer modulators through the use of an innovative polymer cladding design that is amenable for high-volume foundry fabrication when integrated with silicon photonics. This allows our proprietary polymers to perform more effectively and to be fabricated by silicon foundries in a high-volume manufacturing environment.
Taken together, these new patents showcase the depth of our achievements to the industry and position us for ubiquity. We continue to file patents to strengthen our position in the areas of organic chemistry, polymer device fabrication and design, and polymer device packaging.
Groundbreaking Results & Performance Metrics
Beyond patents for our technology, we also made several incredible achievements from a performance perspective. Our latest commercial-class EO polymer material achieved breakthrough performance metrics at 1310 nanometers (nm), a wavelength popular in hyperscale datacenter applications. The achievement of these results at the 1310nm bandwidth positions us well for potential near-term licensing opportunities in datacenter applications. We also achieved record optical modulator performance using our latest Perkinamine® Series 5 material at extremely low cryogenic temperatures, delivering the potential to revolutionize applications in supercomputers, quantum circuits and advanced computing systems.
Commercial Outreach & Business Development
Throughout the year we continued to maintain industry thought leadership through speaking at key industry conferences worldwide. We recently participated in an industry panel discussion at the Optica Photonic-Enabled Cloud Computing Industry Summit, focusing on bringing world leading companies together in the supply chain to discuss the innovations and deployment of optics in data center applications and beyond. Earlier in the year, we also presented and participated in industry panels at the Photonics Spectra Conference and Laser Focus World Executive Forum events – further building thought leadership. Notably, we were again invited to co-chair the Photonic Integrated Circuits (PIC) International Conference – with prominent positions at impactful industry events such as these representing a key driver of the accelerating interest for our technology that we have seen this year.
These industry conferences not only provide an opportunity to evangelize the benefits of our platform to industry leaders, but also serve as forums to hold constructive meetings with decision makers at our target customer companies. At these meetings we receive insight on where end-users are heading and what performance they are looking for from polymer modulator technologies, and we have received multiple requests for prototypes and licensing inquiries as a result.
Market Positioning with Artificial Intelligence
During 2023, we positioned ourselves to show value for internet and optical network operators in the growing artificial intelligence (AI) markets. We have seen that our technology platform dovetails perfectly with the increased generation of information and data that needs to be communicated using fiber optic interconnects and datacenters in general. We all are aware that AI has been integrated deeper within our daily activities with applications to make us more efficient and possibly smarter. The impact on the internet is huge, and the internet is based on an optical network that utilizes data centers to route and switch traffic or information to and from destinations.
Data centers are being upgraded today in a fashion that the industry has not seen before. The expected demands of increased traffic, information, and data driven by AI is changing the way the internet is being operated. AI is now creating new and interesting market opportunities to upgrade the internet. Three of these are important today: density, speed, and low power and these are very well aligned with our high performance electro-optic polymers. We are designing high performance polymer modulator optical engines to support the rise and growth of AI as it generates more information that will travel through the internet and optical networks.
Today's Benzinga All-Access Interview
I will be hosting a fireside chat today with the hosts of the Benzinga All-Access show to discuss this shareholder letter, recent milestone achievements and potential near-term catalysts. Webcast details are shown below.
Benzinga All-Access Show
Date: Monday, December 4, 2023
Presentation Time: 11:30 a.m. Eastern time
Webcast: https://youtube.com/live/CEZ51a_HTpY?feature=share
I would encourage all of our shareholders to tune in for the discussion. A live audio webcast and an archived replay will be available using the webcast link above.
2024 Goals & Final Thoughts
In 2023, we validated our business plan with the initial commercialization of our technology. Our progress was further validated by positive discussions for potential future licensing agreements with a variety of companies. Our technology continues to be recognized for driving innovative change in our industry.
Looking ahead, with the team, technology, intellectual property assets and operational capabilities in place to support our commercialization at scale, we firmly believe that we are well positioned for a future of electro-optic polymer ubiquity. As we move through 2024, we expect continued momentum in our material supply and license agreement program and product design platform that will expand on an exciting new era of commercialization to help to make our next-generation technologies truly ubiquitous in the global internet infrastructure of the future. At no time in history have I been more confident of Lightwave Logic's potential, and I look forward to sharing exciting new milestones during the balance of this year and in the next year to come.
Sincerely,
Dr. Michael Lebby
Chairman and Chief Executive Officer
Your post is pure fiction.....
Dear Fellow Shareholders,
2023 has been a transformational year for Lightwave Logic, underscored by the first commercial material supply and license agreement for our electro-optic polymer materials and ongoing efforts to build on this commercialization momentum. Throughout the year we focused on industry awareness efforts, evangelizing the benefits of our platform at leading industry events globally. We received the "2023 Most Innovative Product – Hybrid PIC/Optical Integration Platform Award at this year's ECOC Exhibition Industry. We are engaging with a variety of companies to discuss product design, device prototype sampling, and material supply and licensing agreements. Operationally, we completed the expansion of our new laboratory production facilities and added key team members to enable our anticipated growth. Supporting these efforts, we continued to fortify our intellectual property position with new patent issuances and patent applications.
Commercialization of EO Polymer Materials
We signed a four (4) year material supply and license agreement for Perkinamine® in May 2023 with a company designing and providing polymer based photonic devices and photonic integrated circuits (PICs). We believe this agreement demonstrates tangible commercial progress for electro-optic polymers as well as market acceptance. We made significant progress throughout the year, with delivery of material to support our licensee.
Per the terms of the non-exclusive material supply and license agreement, the licensee shall pay Lightwave Logic a running royalty with a minimum royalty paid on an annual basis over the term of the License Agreement. Revenue will be generated from royalties from the licensee's sale of licensed products.
In addition to this first licensee, we continue to receive strong interest from other potential customers in our innovative device platform and licensing our technologies. We are working hard to close additional commercial agreements by year end, but since, these are long deliberate processes, we can't guarantee that we will do so. We are presently working with a wide spectrum of companies including multinational tier-1 corporations which manufacture data communications network equipment. Several tier-1 manufacturers have also requested to meet and test our polymer modulators, while fiber optic transceiver companies have expressed interest in learning how to implement our polymer modulators into their ongoing 800G transceiver development programs. Also of note, we are planning to implement our PIC designs using commercial semiconductor foundries for multi-channel polymer modulator engines, including 4 channel solutions for 800G. We believe these constructive discussions are positioning us to capitalize on our momentum with additional licensees as we continue to build excitement around our technology.
Facility & Team in Place to Support Commercialization
During the year we aligned operations with our commercial business plans with a significant laboratory expansion to support volume scale of our EO chromophore materials and new commercial activity. We completed new laboratory production facilities, expanding the corporate facility in Englewood, Colorado by nearly 10,000 square feet for a total of approximately 23,500 square feet. The renovations and installation of new laboratory and engineering facilities expands the size of our facility by over 65%, enabling commercial device testing and evaluation, product reliability testing, high speed optical characterization, SEM analysis and the expansion of our chemical synthesis production line. The facilities are being utilized to provide Perkinamine® chromophore materials for polymer based photonic devices and PICs, and the multiple requests for our prototypes.
To support our commercialization advancement, we added several new key team members in 2023. At the staff level, these new team members included organic chemists as well as additional photonics design, packaging, reliability engineers, and finance personnel to further enhance our in-house capabilities.
At the Board level, the Board of Directors appointed respected industry executive Laila Partridge to the Board. Laila brings a 30+ year track record of executing transactions in the technology space. Her knowledge of both the fiber optic communications markets as well as non-communications markets (such as artificial intelligence, consumer, display, sensing, medical, biotech, etc.) will help us hone business strategies for growing our electro-optic polymer business.
Fortifying Our Intellectual Property Portfolio
We continued to fortify our intellectual property portfolio in 2023 with two new U.S. patents issued and one patent allowed, and expected to be issued in the near future. In addition, we had a further six patent applications published, outlining new inventions to further improve our technology offering. One notable patent issuance was for continued advanced chemical structural design and process that enhances the overall efficiency of poling non-linear organic optical chromophores while simultaneously improving thermal and photostability above what is already an acceptable performance. Finally, we received a patent for a cutting-edge design technique, enhancing the performance of polymer modulators through the use of an innovative polymer cladding design that is amenable for high-volume foundry fabrication when integrated with silicon photonics. This allows our proprietary polymers to perform more effectively and to be fabricated by silicon foundries in a high-volume manufacturing environment.
Taken together, these new patents showcase the depth of our achievements to the industry and position us for ubiquity. We continue to file patents to strengthen our position in the areas of organic chemistry, polymer device fabrication and design, and polymer device packaging.
Groundbreaking Results & Performance Metrics
Beyond patents for our technology, we also made several incredible achievements from a performance perspective. Our latest commercial-class EO polymer material achieved breakthrough performance metrics at 1310 nanometers (nm), a wavelength popular in hyperscale datacenter applications. The achievement of these results at the 1310nm bandwidth positions us well for potential near-term licensing opportunities in datacenter applications. We also achieved record optical modulator performance using our latest Perkinamine® Series 5 material at extremely low cryogenic temperatures, delivering the potential to revolutionize applications in supercomputers, quantum circuits and advanced computing systems.
Commercial Outreach & Business Development
Throughout the year we continued to maintain industry thought leadership through speaking at key industry conferences worldwide. We recently participated in an industry panel discussion at the Optica Photonic-Enabled Cloud Computing Industry Summit, focusing on bringing world leading companies together in the supply chain to discuss the innovations and deployment of optics in data center applications and beyond. Earlier in the year, we also presented and participated in industry panels at the Photonics Spectra Conference and Laser Focus World Executive Forum events – further building thought leadership. Notably, we were again invited to co-chair the Photonic Integrated Circuits (PIC) International Conference – with prominent positions at impactful industry events such as these representing a key driver of the accelerating interest for our technology that we have seen this year.
These industry conferences not only provide an opportunity to evangelize the benefits of our platform to industry leaders, but also serve as forums to hold constructive meetings with decision makers at our target customer companies. At these meetings we receive insight on where end-users are heading and what performance they are looking for from polymer modulator technologies, and we have received multiple requests for prototypes and licensing inquiries as a result.
Market Positioning with Artificial Intelligence
During 2023, we positioned ourselves to show value for internet and optical network operators in the growing artificial intelligence (AI) markets. We have seen that our technology platform dovetails perfectly with the increased generation of information and data that needs to be communicated using fiber optic interconnects and datacenters in general. We all are aware that AI has been integrated deeper within our daily activities with applications to make us more efficient and possibly smarter. The impact on the internet is huge, and the internet is based on an optical network that utilizes data centers to route and switch traffic or information to and from destinations.
Data centers are being upgraded today in a fashion that the industry has not seen before. The expected demands of increased traffic, information, and data driven by AI is changing the way the internet is being operated. AI is now creating new and interesting market opportunities to upgrade the internet. Three of these are important today: density, speed, and low power and these are very well aligned with our high performance electro-optic polymers. We are designing high performance polymer modulator optical engines to support the rise and growth of AI as it generates more information that will travel through the internet and optical networks.
Today's Benzinga All-Access Interview
I will be hosting a fireside chat today with the hosts of the Benzinga All-Access show to discuss this shareholder letter, recent milestone achievements and potential near-term catalysts. Webcast details are shown below.
Benzinga All-Access Show
Date: Monday, December 4, 2023
Presentation Time: 11:30 a.m. Eastern time
Webcast: https://youtube.com/live/CEZ51a_HTpY?feature=share
I would encourage all of our shareholders to tune in for the discussion. A live audio webcast and an archived replay will be available using the webcast link above.
2024 Goals & Final Thoughts
In 2023, we validated our business plan with the initial commercialization of our technology. Our progress was further validated by positive discussions for potential future licensing agreements with a variety of companies. Our technology continues to be recognized for driving innovative change in our industry.
Looking ahead, with the team, technology, intellectual property assets and operational capabilities in place to support our commercialization at scale, we firmly believe that we are well positioned for a future of electro-optic polymer ubiquity. As we move through 2024, we expect continued momentum in our material supply and license agreement program and product design platform that will expand on an exciting new era of commercialization to help to make our next-generation technologies truly ubiquitous in the global internet infrastructure of the future. At no time in history have I been more confident of Lightwave Logic's potential, and I look forward to sharing exciting new milestones during the balance of this year and in the next year to come.
Sincerely,
Dr. Michael Lebby
Chairman and Chief Executive Officer
Lightwave has an exclusive patented product, no competition.
They can't announce a deal until the customer announces the product.
This following article was just posted in January. Note the timeline given in the chart. It's industry timing that we are talking about - not Lightwave delays.
(note - block data can be found here https://investorshub.advfn.com/Xenas-Study-Hall-2991)
Polymer silicon-organic-hybrid (SOH)67,72 and plasmonic-organic-hybrid (POH)69 require poling and hermetic sealing, creating significant challenges to making stable devices. Their high-temperature reliability and reflow compatibility need to be further demonstrated, although recent results are promising72. POH modulators, even though they look attractive in the PPA metrics, further suffer from compatibility with CMOS SOI foundries. Good plasmonic metals (Cu, Ag, Au) are also serious contaminants, and need diffusion barrier layers (e.g., TaN) which are optically very lossy.
Polycrystalline layers of other ferroelectric thin-film materials such as BTO show much larger Pockels coefficient (expressed in pm/V) than LNOI73 and comparable to polymers74, and recent demonstrations of large E/O BW65,75 make them promising. Note that a large Pockels coefficient in the device is important, which requires a good overlap of the electric modulation field and the propagating optical mode49,72. As part of the direct wafer bonding process, BTO thin films are fabricated first using molecular beam epitaxy deposition on donor wafers, and then directly wafer bonded to interlayer dielectric/SiO2 of the planarized acceptor SOI wafer using intermediate alumina layers as an adhesive. BTO also requires poling to compensate for hysteresis from ferroelectric domain switching (albeit only?~?1V DC compared to much larger voltages needed for polymer modulators)65. Sources of propagation loss include scattering from waveguide sidewall roughness and residual oxygen vacancies in the BTO thin film—areas for further improvement. BTO also has a lower refractive index compared to Si (nBTO = 2.38, nSi = 3.47 @ 1550 nm) and a significantly large RF relative permittivity that can increase capacitances and velocity mismatch between the optical and electrical fields.
Lightwave has an exclusive patented product, no competition.
They can't announce a deal until the customer announces the product.
This article was just posted in January. Note the timeline given in the chart. It's industry timing that we are talking about - not Lightwave delays.
Polymer silicon-organic-hybrid (SOH)67,72 and plasmonic-organic-hybrid (POH)69 require poling and hermetic sealing, creating significant challenges to making stable devices. Their high-temperature reliability and reflow compatibility need to be further demonstrated, although recent results are promising72. POH modulators, even though they look attractive in the PPA metrics, further suffer from compatibility with CMOS SOI foundries. Good plasmonic metals (Cu, Ag, Au) are also serious contaminants, and need diffusion barrier layers (e.g., TaN) which are optically very lossy.
Polycrystalline layers of other ferroelectric thin-film materials such as BTO show much larger Pockels coefficient (expressed in pm/V) than LNOI73 and comparable to polymers74, and recent demonstrations of large E/O BW65,75 make them promising. Note that a large Pockels coefficient in the device is important, which requires a good overlap of the electric modulation field and the propagating optical mode49,72. As part of the direct wafer bonding process, BTO thin films are fabricated first using molecular beam epitaxy deposition on donor wafers, and then directly wafer bonded to interlayer dielectric/SiO2 of the planarized acceptor SOI wafer using intermediate alumina layers as an adhesive. BTO also requires poling to compensate for hysteresis from ferroelectric domain switching (albeit only?~?1V DC compared to much larger voltages needed for polymer modulators)65. Sources of propagation loss include scattering from waveguide sidewall roughness and residual oxygen vacancies in the BTO thin film—areas for further improvement. BTO also has a lower refractive index compared to Si (nBTO = 2.38, nSi = 3.47 @ 1550 nm) and a significantly large RF relative permittivity that can increase capacitances and velocity mismatch between the optical and electrical fields.
DFCO uplist???? That's hysterical.
It's much more likely that BONAR is getting ready to take the DFCO shell private....
.... AGAIN....
Please note that a share reduction is not a share buyback.
Company reduces authorized shares and satisfies debt, cleaning up capitalization to lay the groundwork for anticipated growth and future success.
SAN DIEGO, CA / ACCESSWIRE / March 14, 2024 / Dalrada Financial Corporation (OTCQB:DFCO), ("Dalrada," "the Company"), announced today that it had filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC), highlighting the Company's decision to reduce its number of authorized common shares from 1 billion to 500 million.
The share reduction announcement comes just weeks after Dalrada filed another 8-K in which CEO and Founder, Brian Bonar, addressed shareholders about the major events of the past year, setting up the Company's ambitious goals for 2024 and beyond-particularly within the climate technology and healthcare sectors.
"I'm pleased to say that we've been able to form a solid foundation for Dalrada's progress and future success," according to Bonar. "Our intention is to expand upon our company wins in multiple business markets and keep that momentum going," he added.
In addition to the overall share reduction, the Company successfully converted a total of approximately $34 million in related party debt to preferred stock during fiscal year ending 2023.
Dalrada's authorized common share reduction and debt conversion to preferred stock show the Company's commitment to improving value for every shareholder while signaling the strength of its subsidiaries and core product offerings.
https://www.accesswire.com/842862/dalrada-corporation-announces-authorized-share-reduction-highlighting-huge-growth-potential-in-8-k-filing
Yes. I also got to go to the grand opening of Wal-Mart a few blocks from my grandmother's house.
Actually it's a quadruple bottom for LWLG. Institutions entered at the highs and loaned their shares to the shorts and it's been monkey business ever since.
What they haven't accounted for in their algos is that private parties in the EU own more stock than the institutions and they aren't selling.
Commercialization and revenues are imminent... shorts are screwed because the can't cover.
Lebby has stated multiple times that commercialization and revenues will kick in this year.
Cash on hand is sufficient. I expect no dilution at these levels and it's quite possible that there will never be any more dilution.
Your "based on the chart" is B.S. That's probably why you didn't post a chart.
Denial is not just a river in Egypt...
LOL !!
LOL !!!!!
LOL !!!!!!!
No spec sheets... EOM.
Uh oh...
An OMG moment.
Tyson was a major employer in my Mom's home town.
https://www.tysonfoods.com/who-we-are/our-story/where-we-came-from/our-history
Mom was the oldest in a family of 11. Several of them started their work history with Tyson.
Yes, I haven't figured you how DM got to be so cheap yet. It seems to have valid ongoing relationshipts.
IMO - it's a wonderful candidate for discussion and joint DD on Xena's Study Hall.
WRONG - it isn't about "post-hoc analysis"
Limitations of the biopsychosocial model in psychiatry
Tony B Benning
Author information Copyright and License information PMC Disclaimer
Go to:
Abstract
A commitment to an integrative, non-reductionist clinical and theoretical perspective in medicine that honors the importance of all relevant domains of knowledge, not just “the biological,” is clearly evident in Engel’s original writings on the biopsychosocial model. And though this model’s influence on modern psychiatry (in clinical as well as educational settings) has been significant, a growing body of recent literature is critical of it – charging it with lacking philosophical coherence, insensitivity to patients’ subjective experience, being unfaithful to the general systems theory that Engel claimed it be rooted in, and engendering an undisciplined eclecticism that provides no safeguards against either the dominance or the under-representation of any one of the three domains of bio, psycho, or social.
U.S. Securities Class Actions - An Overview
By Elizabeth L. Yingling
A. Background
Securities fraud class action suits are the most common manner by which a large group of
shareholders seeks to recover damages based upon claims of fraudulent statements made in
connection with the purchase or sale of a security. These cases are routinely filed after the
announcement of negative news about a company, followed by a drop in the price of the
company’s securities. Unfortunately, the “named plaintiffs” generally have very little to do
with the lawsuit. Rather, these large suits are run by plaintiffs’ law firms. To the extent that
the case is not ultimately dismissed, and monies are paid by the defendants through either a
judgment or a settlement, the shareholders themselves very rarely see much of the money.
Rather, the plaintiffs’ lawyers receive roughly 40% of any settlement or judgment, in
addition to monies to cover the costs they have incurred.
Because of the expense associated with defending securities fraud class action suits,
defendants often determine to settle the suits quickly. As a result, historically, the plaintiffs’
bar has often instituted frivolous “strike” suits in order to extract a quick settlement. In
recognition of the inappropriateness of these “strike” suits, in 1995, the U.S. Congress
enacted the Private Securities Litigation Reform Act (“PSLRA”). While the PSLRA did
codify certain standards of pleading that a plaintiff must meet in order to maintain a
securities fraud class action suit, ultimately, the PSLRA has not been much of a deterrent
against such frivolous suits.
Very few securities fraud class action suits are tried to a Judge or Jury. Rather, the cases are
either (1) dismissed at an early stage of the case pursuant to a motion to dismiss; (2)
dismissed when a court determines that a class cannot be properly certified; (3) dismissed as
a result of a motion for summary judgment; or (4) settled.
DUH!!!!
You say " The issue of merit will be decided by a court if the litigation proceeds that far."
When will the court consider a lawsuit to be frivolous?
A court will dismiss a lawsuit as being frivolous or without merit if it finds:
There are no reasonable or factual grounds to support the underlying claim
The lawsuit was intended to harass or to tie up the defendant in litigation
Attorneys who file a lawsuit in bad faith and the claim is frivolous or designed to cause unnecessary delay may be held accountable for the other party’s legal fees and court costs. Because attorneys are discouraged from filing a claim without merit, you need to take all legal actions seriously.
Nope - " the plaintiff had specific accusations and had provided detailed evidence in support of his claim" is an argument in support of "merit"
Thanks for reinforcing my point.
Statistical analysis of biotech trials is very complex.
From the complaint:
17. Until January 15, 2022, Defendants represented Anavex would use particular
primary and secondary research outcomes for its Avatar study about adult Rett syndrome. On
February 1, 2022, the Company released its Avatar study results. The actual methods and outcomes
used to analyze the Avatar study were different from those previously announced. Analysts
critiqued these methods as being unusual and not clinically validated. Nonetheless, the Company
persisted and claimed it would use these same tests for analysis of its Excellence trial about
pediatric Rett syndrome.
Skip to main content
Taylor & Francis Group Logo
T&F eBooks
Search for keywords, authors, titles, ISBN
Advanced Search
About Us
Subjects
Browse
Products
Request a trial
Librarian Resources
What's New!!
HomeBiosciencePharmaceutical ScienceClinical Trials - Pharmaceutical ScienceStatistical Design, Monitoring, and Analysis of Clinical Trials
Statistical Design, Monitoring, and Analysis of Clinical Trials
Book
Statistical Design, Monitoring, and Analysis of Clinical Trials
Principles and Methods
ByWeichung Joe Shih, Joseph Aisner
Edition2nd Edition
First Published2021
eBook Published25 October 2021
Pub. LocationNew York
ImprintChapman and Hall/CRC
DOIhttps://doi.org/10.1201/9781003176527
Pages404
eBook ISBN9781003176527
SubjectsBioscience, Mathematics & Statistics, Medicine, Dentistry, Nursing & Allied Health
Share
Share
Citation
ABSTRACT
Statistical Design, Monitoring, and Analysis of Clinical Trials, Second Edition concentrates on the biostatistics component of clinical trials. This new edition is updated throughout and includes five new chapters.
Developed from the authors’ courses taught to public health and medical students, residents, and fellows during the past 20 years, the text shows how biostatistics in clinical trials is an integration of many fundamental scientific principles and statistical methods. The book begins with ethical and safety principles, core trial design concepts, the principles and methods of sample size and power calculation, and analysis of covariance and stratified analysis. It then focuses on sequential designs and methods for two-stage Phase II cancer trials to Phase III group sequential trials, covering monitoring safety, futility, and efficacy. The authors also discuss the development of sample size reestimation and adaptive group sequential procedures, phase 2/3 seamless design and trials with predictive biomarkers, exploit multiple testing procedures, and explain the concept of estimand, intercurrent events, and different missing data processes, and describe how to analyze incomplete data by proper multiple imputations.
This text reflects the academic research, commercial development, and public health aspects of clinical trials. It gives students and practitioners a multidisciplinary understanding of the concepts and techniques involved in designing, monitoring, and analyzing various types of trials. The book’s balanced set of homework assignments and in-class exercises are appropriate for students and researchers in (bio)statistics, epidemiology, medicine, pharmacy, and public health.
TABLE OF CONTENTS
Chapter 1|28 pages
Overview
Abstract
Chapter 2|23 pages
Concepts and Methods of Statistical Designs
Abstract
Chapter 3|10 pages
Efficiency with Trade-Offs and Crossover Designs
Abstract
Chapter 4|40 pages
Sample Size and Power Calculations
Abstract
Chapter 5|34 pages
Analysis of Covariance and Stratified Analysis
Abstract
Chapter 6|30 pages
Regression Analysis of Survival Data
Abstract
Chapter 7|13 pages
Sequential Designs and Methods—Part I: Expected Sample Size and Two-Stage Phase II Trials in Oncology
Abstract
Chapter 8|21 pages
Sequential Designs and Methods—Part II: Monitoring Safety and Futility
Abstract
Chapter 9|28 pages
Sequential Designs and Methods—Part III: Classical Group Sequential Trials
Abstract
Chapter 10|32 pages
Monitoring the Maximum Information and Adaptive Sample Size Designs
Abstract
Chapter 11|19 pages
Multiplicity Issues and Methods for Controlling the Type I Error Rate
Abstract
Chapter 12|18 pages
Clinical Trials with Predictive Biomarkers
Abstract
Chapter 13|18 pages
Seamless Phase II/III: Select-the-Winner Design
Abstract
Chapter 14|14 pages
Statistical Significance and p-Values
Abstract
Chapter 15|34 pages
Estimand, Intercurrent Events, and Missing Data
Abstract
You do not have access to this content currently. Please click 'Get Access' button to see if you or your institution have access to this content.
To purchase a print version of this book for personal use or request an inspection copy
METRICS
33 total citations on Dimensions.
Citations
Taylor & Francis Group Logo
Policies
Privacy Policy
Terms & Conditions
Cookie Policy
Journals
Taylor & Francis Online
Corporate
Taylor & Francis Group
Help & Contact
Students/Researchers
Librarians/Institutions
Connect with us
Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG© 2024 Informa UK Limited
Back to Top
Lordy - what a mess...
Something only a computer programmer could love.
Seems like a great way to front load the day's AI trading, or to balance the books end of day.
Your argument is silly, specious, and absurd...
BIOChecker4 didn't make any arguments. All he did was to make a brief statement about what is contained in the Plaintiff's Complaint. Why should he cut and paste a twenty-five page document here on the board when all you have to do is read the linked PDF file?
You made an argument with out basing it in fact ---
That's total B.S.
Roughly 6.5 million AVXL shares traded today..
I am wondering what the meaning of this is so here is the collected data to be discussed.
There are two numbers with Medved Trader. The second, lower number is usually zero until updated after market. Today the 6.5 million number is showing. The number showing at close is usually different from the cut and paste but proves to be accurate in the long run.
One and two million days aren't that unsusual, but I used three million as a threshold. I would love for someone to explain this....
03/15/24 5.09 5.28 5.08 5.105 6,590,753
03/15/24 5.09 5.28 5.08 5.105 340,396
03/14/24 5.34 5.36 5.09 5.14 1,249,399
03/13/24 5.27 5.5732 5.185 5.38 1,302,716
03/12/24 5.21 5.30 5.08 5.20 1,151,309
03/11/24 5.43 5.515 5.1603 5.19 1,446,321
03/08/24 5.23 5.48 5.2221 5.45 1,139,994
03/07/24 5.10 5.34 5.03 5.19 1,393,902
03/06/24 5.08 5.11 4.96 5.02 1,213,041
03/05/24 5.05 5.15 4.96 4.98 913,480
03/04/24 5.33 5.35 4.985 5.11 1,003,137
03/01/24 5.19 5.4187 5.125 5.28 990,157
02/29/24 5.43 5.5076 5.115 5.14 1,003,136
02/28/24 5.26 5.3962 5.21 5.30 811,516
02/27/24 5.02 5.37 4.95 5.33 1,583,899
02/26/24 4.95 5.05 4.795 4.98 1,609,290
02/23/24 5.00 5.14 4.87 4.92 1,612,166
02/22/24 5.07 5.1199 4.95 5.01 1,862,210
02/21/24 5.38 5.44 5.04 5.08 1,360,342
02/20/24 5.60 5.665 5.32 5.36 1,083,108
02/16/24 5.74 5.82 5.63 5.67 785,961
02/15/24 5.88 5.97 5.64 5.83 862,044
02/14/24 5.68 5.91 5.5501 5.84 706,914
02/13/24 5.94 5.95 5.52 5.575 1,175,427
02/12/24 5.82 6.15 5.8108 6.14 972,878
02/09/24 5.77 5.8301 5.65 5.78 830,613
02/08/24 5.66 5.80 5.53 5.69 1,129,527
02/07/24 5.94 6.02 5.47 5.59 1,558,122
02/06/24 5.31 5.79 5.30 5.79 1,580,378
02/05/24 5.69 5.71 5.29 5.36 1,814,262
02/02/24 6.04 6.11 5.7031 5.73 1,625,577
02/01/24 6.00 6.15 5.87 6.15 810,153
01/31/24 6.27 6.361 5.97 5.97 1,046,260
01/30/24 6.67 6.67 6.29 6.29 1,027,371
01/29/24 6.34 6.819 6.25 6.75 976,884
01/26/24 6.73 6.8989 6.31 6.33 1,022,525
01/25/24 6.58 6.729 6.48 6.64 771,657
01/24/24 6.73 6.83 6.57 6.58 849,865
01/23/24 6.70 6.80 6.47 6.60 738,712
01/22/24 6.09 6.62 6.09 6.60 1,334,425
01/19/24 6.01 6.10 5.8002 6.05 1,209,988
01/18/24 6.10 6.10 5.90 6.01 730,082
01/17/24 5.87 6.065 5.75 6.05 791,382
01/16/24 5.96 6.011 5.785 5.98 1,276,698
01/12/24 6.03 6.20 5.91 5.99 1,365,632
01/11/24 6.20 6.20 5.95 6.01 1,565,453
01/10/24 6.40 6.54 6.19 6.25 1,163,170
01/09/24 6.46 6.535 6.34 6.41 1,115,047
01/08/24 5.94 6.56 5.83 6.56 2,041,916
01/05/24 6.15 6.18 5.9401 6.01 2,444,235
01/04/24 6.59 6.85 6.21 6.29 2,533,235
01/03/24 6.09 6.9315 6.00 6.53 3,362,978
01/02/24 5.90 6.95 5.79 6.045 9,264,803
12/29/23 9.58 9.58 9.26 9.31 1,014,673
12/28/23 9.91 10.066 9.44 9.60 1,269,351
12/27/23 9.42 9.91 9.36 9.91 1,380,072
12/26/23 9.08 9.4799 8.94 9.38 1,240,488
12/22/23 8.83 9.40 8.80 8.95 1,267,955
12/21/23 9.325 9.3409 8.50 8.75 1,977,454
12/20/23 9.95 10.21 8.75 8.85 2,574,989
12/19/23 9.00 10.45 8.9307 9.95 4,297,183
12/18/23 8.95 9.13 8.6994 8.79 1,007,676
12/15/23 8.87 9.00 8.69 8.84 1,813,185
12/14/23 8.60 8.90 8.60 8.78 1,331,289
12/13/23 7.90 8.45 7.84 8.45 1,138,570
12/12/23 7.85 8.03 7.79 7.89 851,847
12/11/23 8.01 8.02 7.66 7.91 711,916
12/08/23 8.12 8.24 7.93 7.96 694,745
12/07/23 8.02 8.19 7.92 8.13 815,007
12/06/23 8.09 8.19 7.915 8.01 834,826
12/05/23 8.15 8.17 7.93 7.95 965,659
12/04/23 7.61 8.32 7.58 8.20 1,337,229
12/01/23 7.15 7.62 7.01 7.57 1,070,483
11/30/23 7.27 7.42 7.0719 7.21 1,182,373
11/29/23 6.88 7.23 6.83 7.09 1,148,592
11/28/23 6.53 6.86 6.29 6.78 860,438
11/27/23 6.85 7.00 6.18 6.36 2,262,983
11/24/23 6.85 7.2494 6.81 7.07 676,612
11/22/23 6.76 6.8869 6.535 6.70 948,214
11/21/23 6.9995 7.54 6.70 6.72 2,403,049
11/20/23 7.00 7.0747 6.62 7.00 2,155,816
11/17/23 6.09 6.33 6.011 6.27 760,821
11/16/23 6.22 6.22 5.8746 6.01 866,093
11/15/23 6.25 6.54 6.17 6.18 946,968
11/14/23 6.04 6.24 5.98 6.22 1,182,876
11/13/23 5.63 5.77 5.47 5.75 712,183
11/10/23 5.80 5.83 5.55 5.74 733,258
11/09/23 5.98 6.01 5.65 5.71 1,210,742
11/08/23 6.21 6.27 5.87 5.97 1,150,794
11/07/23 5.97 6.23 5.87 6.21 1,360,828
11/06/23 6.02 6.14 5.84 5.93 773,838
11/03/23 5.71 6.18 5.60 6.04 1,255,000
11/02/23 5.62 5.78 5.525 5.69 891,245
11/01/23 5.57 5.69 5.455 5.62 620,479
10/31/23 5.45 5.645 5.32 5.58 744,195
10/30/23 5.19 5.55 5.19 5.50 722,704
10/27/23 5.65 5.78 5.175 5.20 1,014,042
10/26/23 5.62 5.91 5.48 5.62 1,107,385
10/25/23 5.17 5.70 5.04 5.59 1,747,445
10/24/23 5.15 5.36 4.98 5.13 1,281,654
10/23/23 5.14 5.2395 4.90 5.04 1,261,674
10/20/23 5.61 5.6599 5.16 5.20 1,600,626
10/19/23 5.66 5.69 5.53 5.59 556,951
10/18/23 5.94 5.95 5.61 5.65 657,528
10/17/23 6.02 6.19 5.99 5.99 597,555
10/16/23 6.05 6.13 5.9131 6.06 490,642
10/13/23 5.89 6.22 5.80 6.05 790,758
10/12/23 6.19 6.25 5.84 5.89 900,042
10/11/23 6.33 6.43 6.145 6.19 496,351
10/10/23 6.09 6.375 5.92 6.32 745,722
10/09/23 6.05 6.14 5.975 6.14 655,911
10/06/23 6.36 6.39 6.11 6.14 698,958
10/05/23 6.34 6.49 6.295 6.41 618,507
10/04/23 6.23 6.395 6.1702 6.35 693,209
10/03/23 6.30 6.325 6.095 6.26 836,713
10/02/23 6.57 6.63 6.29 6.36 828,452
09/29/23 6.81 6.85 6.515 6.55 898,145
09/28/23 6.81 6.82 6.60 6.72 607,717
09/27/23 6.83 6.95 6.665 6.81 547,953
09/26/23 6.74 7.04 6.74 6.80 606,126
09/25/23 6.85 6.9101 6.7499 6.79 549,032
09/22/23 7.00 7.00 6.84 6.89 668,733
09/21/23 7.13 7.20 6.86 6.97 768,865
09/20/23 7.12 7.92 7.07 7.24 1,467,088
09/19/23 7.12 7.13 6.81 7.12 1,119,280
09/18/23 7.79 7.84 7.065 7.13 1,660,138
09/15/23 8.00 8.0299 7.55 7.57 2,941,032
09/14/23 7.98 8.3899 7.57 7.95 2,770,282
09/13/23 7.73 8.02 7.64 7.66 738,376
09/12/23 7.75 7.85 7.67 7.75 656,619
09/11/23 7.87 7.90 7.65 7.75 626,961
09/08/23 7.72 7.88 7.64 7.87 653,361
09/07/23 7.75 7.83 7.68 7.71 798,330
09/06/23 7.84 7.89 7.71 7.81 672,631
09/05/23 7.92 8.02 7.80 7.87 573,983
09/01/23 7.92 8.09 7.875 7.94 574,135
08/31/23 7.90 8.02 7.80 7.90 715,021
08/30/23 7.94 8.02 7.8219 7.92 536,305
08/29/23 7.91 7.98 7.765 7.95 598,769
08/28/23 8.07 8.15 7.874 7.93 409,031
08/25/23 7.86 8.08 7.7626 8.04 603,374
08/24/23 8.03 8.08 7.595 7.75 1,000,793
08/23/23 8.18 8.23 8.00 8.02 400,281
08/22/23 8.21 8.28 8.01 8.14 492,302
08/21/23 8.16 8.3201 8.01 8.17 614,083
08/18/23 8.01 8.33 7.97 8.16 467,810
08/17/23 8.60 8.75 8.10 8.12 961,832
08/16/23 8.88 8.885 8.62 8.62 667,419
08/15/23 9.06 9.07 8.69 8.94 677,315
08/14/23 8.75 9.15 8.61 9.15 710,441
08/11/23 8.94 9.01 8.68 8.82 571,306
08/10/23 9.30 9.89 8.94 9.05 1,983,246
08/09/23 8.13 9.46 8.08 9.37 3,091,301
08/08/23 8.00 8.07 7.5806 8.03 1,131,164
08/07/23 8.18 8.21 7.63 7.68 1,072,514
08/04/23 8.30 8.50 8.19 8.22 650,810
08/03/23 8.16 8.36 8.10 8.30 666,223
08/02/23 8.04 8.31 7.965 8.22 624,528
08/01/23 8.21 8.23 7.97 8.15 683,015
07/31/23 7.94 8.27 7.935 8.25 745,856
07/28/23 7.70 7.95 7.66 7.93 675,354
07/27/23 8.04 8.06 7.6201 7.66 1,040,508
07/26/23 8.03 8.10 7.95 7.99 481,492
07/25/23 8.14 8.22 7.93 8.02 547,522
07/24/23 7.91 8.21 7.91 8.17 718,754
07/21/23 8.08 8.17 7.92 8.11 778,051
07/20/23 8.25 8.29 7.9909 8.00 555,303
07/19/23 8.38 8.49 8.2916 8.33 426,044
07/18/23 8.40 8.57 8.365 8.38 426,909
07/17/23 8.41 8.56 8.27 8.37 1,006,859
07/14/23 8.46 8.54 8.34 8.42 484,542
07/13/23 8.57 8.62 8.43 8.45 398,155
07/12/23 8.71 8.71 8.4399 8.55 548,358
07/11/23 8.63 8.74 8.485 8.61 537,648
07/10/23 8.14 8.68 8.13 8.66 1,057,445
07/07/23 7.91 8.18 7.90 8.16 631,574
07/06/23 7.88 7.9175 7.73 7.88 646,955
07/05/23 8.01 8.03 7.80 7.95 755,540
07/03/23 8.13 8.1807 7.925 8.01 570,322
06/30/23 8.01 8.18 7.90 8.13 710,877
06/29/23 7.98 8.20 7.87 7.91 874,459
06/28/23 8.09 8.09 7.87 7.98 1,317,731
06/27/23 8.20 8.22 8.01 8.08 688,145
06/26/23 8.12 8.28 8.00 8.20 704,724
06/23/23 8.25 8.25 8.08 8.16 966,319
06/22/23 8.46 8.46 8.26 8.30 590,478
06/21/23 8.36 8.62 8.2201 8.52 608,483
06/20/23 8.53 8.58 8.30 8.41 963,674
06/16/23 8.95 8.96 8.41 8.57 4,097,261
06/15/23 8.76 8.94 8.58 8.83 849,112
06/14/23 8.85 8.935 8.59 8.75 796,239
06/13/23 8.75 8.99 8.51 8.83 884,454
06/12/23 9.20 9.36 8.49 8.655 1,656,815
06/09/23 9.28 10.17 8.91 9.15 3,982,144
06/08/23 9.39 9.4999 9.12 9.24 892,868
06/07/23 9.07 9.47 9.0143 9.38 920,716
06/06/23 9.11 9.215 8.94 9.11 715,458
06/05/23 9.05 9.23 9.03 9.07 702,343
06/02/23 9.17 9.24 8.915 9.14 811,391
06/01/23 9.22 9.34 9.05 9.10 653,851
05/31/23 9.18 9.47 9.00 9.24 683,974
05/30/23 9.45 9.50 9.07 9.18 651,131
05/26/23 8.97 9.355 8.945 9.32 960,729
05/25/23 9.22 9.26 8.88 8.96 711,682
05/24/23 9.17 9.27 9.055 9.21 762,299
05/23/23 9.44 9.7291 9.20 9.26 957,685
05/22/23 9.45 9.59 9.35 9.50 665,369
05/19/23 9.45 9.5299 9.27 9.45 547,935
05/18/23 9.50 9.50 9.03 9.29 734,732
05/17/23 9.09 9.51 8.94 9.50 801,084
05/16/23 9.36 9.38 8.87 9.01 954,695
05/15/23 9.14 9.66 9.07 9.49 884,281
05/12/23 9.26 9.32 8.88 9.10 533,527
05/11/23 9.37 9.45 9.03 9.19 860,401
05/10/23 9.32 9.6299 9.04 9.36 1,250,446
05/09/23 8.15 9.28 8.02 9.07 1,230,245
05/08/23 8.42 8.45 8.20 8.41 880,194
05/05/23 8.50 8.63 8.41 8.44 796,423
05/04/23 8.32 8.485 8.1101 8.40 798,618
05/03/23 8.05 8.50 8.03 8.34 1,268,245
05/02/23 8.28 8.39 7.95 8.00 994,335
05/01/23 8.15 8.27 7.98 8.22 853,997
04/28/23 8.20 8.23 8.05 8.14 692,861
04/27/23 8.31 8.3699 8.06 8.19 727,456
04/26/23 7.76 8.29 7.6601 8.24 1,237,862
04/25/23 7.81 7.88 7.65 7.77 697,888
04/24/23 8.01 8.04 7.68 7.85 621,921
04/21/23 7.97 8.08 7.93 8.03 642,162
04/20/23 8.15 8.15 7.93 7.97 857,550
04/19/23 8.06 8.28 8.00 8.19 605,459
04/18/23 8.16 8.16 7.99 8.12 703,699
04/17/23 7.95 8.26 7.8573 8.13 1,222,660
04/14/23 8.02 8.04 7.645 7.88 866,393
04/13/23 7.69 8.15 7.69 8.07 1,391,473
04/12/23 7.75 7.88 7.59 7.66 696,635
04/11/23 7.70 7.80 7.60 7.67 801,756
04/10/23 7.78 7.78 7.44 7.70 1,250,671
04/06/23 7.87 7.87 7.685 7.79 910,731
04/05/23 7.97 8.10 7.795 7.87 838,425
04/04/23 8.50 8.5113 7.9429 8.07 1,265,141
04/03/23 8.53 8.62 8.36 8.51 835,948
03/31/23 8.45 8.70 8.36 8.57 1,544,409
03/30/23 8.86 8.98 8.25 8.32 2,170,673
03/29/23 8.51 8.59 8.32 8.56 1,050,149
03/28/23 8.50 8.61 8.27 8.32 785,134
03/27/23 8.76 8.80 8.485 8.51 857,996
03/24/23 8.60 8.79 8.42 8.72 1,082,049
03/23/23 8.65 8.92 8.38 8.68 1,203,720
03/22/23 9.07 9.07 8.475 8.52 1,642,298
03/21/23 9.34 9.45 8.92 9.10 1,178,875
03/20/23 9.49 9.495 9.19 9.26 916,955
03/17/23 9.40 9.55 9.21 9.51 1,908,550
03/16/23 9.31 9.7201 9.05 9.54 1,020,423
03/15/23 9.25 9.51 9.15 9.36 1,471,135
03/14/23 9.63 9.86 9.21 9.53 1,323,462
03/13/23 8.59 9.4799 8.59 9.40 1,829,250
03/10/23 9.66 9.66 8.535 8.98 2,218,992
03/09/23 10.15 10.37 9.57 9.68 1,052,112
03/08/23 9.77 10.13 9.74 10.11 905,481
03/07/23 9.88 10.18 9.694 9.83 880,221
03/06/23 9.96 10.01 9.64 9.87 816,010
03/03/23 9.77 10.0475 9.59 9.93 866,174
03/02/23 9.50 9.74 9.37 9.67 745,240
03/01/23 9.52 9.735 9.44 9.68 836,694
02/28/23 9.68 9.82 9.47 9.52 810,555
02/27/23 9.79 9.86 9.565 9.65 747,731
02/24/23 9.80 9.83 9.60 9.72 856,992
02/23/23 10.15 10.18 9.84 9.93 768,802
02/22/23 10.03 10.22 9.99 10.11 756,675
02/21/23 10.38 10.45 9.97 10.00 1,127,474
02/17/23 10.41 10.58 10.25 10.58 747,457
02/16/23 10.33 10.60 10.25 10.42 1,004,762
02/15/23 10.48 10.625 10.285 10.47 745,972
02/14/23 10.43 10.72 10.27 10.60 917,743
02/13/23 10.55 10.671 10.40 10.50 727,780
02/10/23 10.39 10.63 10.18 10.54 777,576
02/09/23 11.04 11.10 10.40 10.41 1,177,320
02/08/23 11.51 11.90 10.9231 10.93 1,419,648
02/07/23 11.00 11.925 10.78 11.75 2,043,120
02/06/23 11.24 11.59 11.11 11.11 1,313,264
02/03/23 11.11 11.59 11.05 11.26 1,073,016
02/02/23 11.09 11.71 10.97 11.37 1,438,366
02/01/23 10.89 11.22 10.57 10.99 1,188,421
01/31/23 10.13 10.89 10.06 10.87 1,377,317
01/30/23 10.74 10.76 9.84 10.05 1,927,351
01/27/23 10.52 10.69 10.41 10.56 615,844
01/26/23 10.91 10.99 10.39 10.52 595,981
01/25/23 10.52 10.83 10.32 10.79 871,965
01/24/23 10.38 10.91 10.2221 10.72 1,157,931
01/23/23 10.33 10.58 10.13 10.47 971,023
01/20/23 10.22 10.41 9.98 10.30 981,763
01/19/23 9.99 10.24 9.65 10.10 1,116,567
01/18/23 10.56 10.75 10.055 10.13 1,206,547
01/17/23 10.50 10.63 10.21 10.46 1,621,981
01/13/23 11.05 11.335 10.15 10.58 2,105,408
01/12/23 10.86 11.24 10.38 11.21 1,923,905
01/11/23 10.39 10.82 10.10 10.80 1,483,107
01/10/23 9.83 10.39 9.775 10.39 1,170,341
01/09/23 10.14 10.17 9.57 9.85 1,121,519
01/06/23 10.02 10.20 9.68 10.00 1,543,951
01/05/23 9.91 9.97 9.46 9.87 1,126,940
01/04/23 9.74 10.09 9.46 9.97 1,366,576
01/03/23 9.89 9.89 9.32 9.68 1,769,013
12/30/22 9.00 9.26 8.91 9.26 1,088,616
12/29/22 8.29 9.28 8.20 9.13 1,862,813
12/28/22 8.11 8.34 8.01 8.19 1,011,516
12/27/22 8.45 8.55 8.13 8.16 1,206,733
12/23/22 8.60 8.69 8.22 8.45 850,624
12/22/22 8.60 8.69 8.2813 8.57 1,204,159
12/21/22 8.68 8.86 8.44 8.61 1,171,623
12/20/22 8.47 8.9084 8.36 8.71 1,094,310
12/19/22 8.65 8.685 8.175 8.51 1,634,836
12/16/22 8.27 8.695 8.185 8.64 3,155,206
12/15/22 8.70 8.80 8.30 8.35 1,537,386
12/14/22 8.68 8.98 8.50 8.83 1,319,980
12/13/22 8.94 9.049 8.37 8.74 1,780,898
12/12/22 7.75 8.85 7.73 8.67 3,394,869
12/09/22 7.99 8.07 7.63 7.65 2,292,232
12/08/22 8.50 8.5237 7.9501 8.08 2,635,981
12/07/22 8.34 9.10 8.31 8.49 2,737,453
12/06/22 9.21 9.2101 8.34 8.38 6,006,781
12/05/22 12.03 12.11 9.56 9.58 8,403,482
12/02/22 12.57 13.23 10.66 12.05 45,682,570
12/01/22 8.90 9.57 8.80 8.87 2,157,524
11/30/22 8.96 9.14 8.29 8.82 4,017,257
11/29/22 9.24 9.46 8.7701 8.94 2,155,419
11/28/22 12.46 12.49 8.865 9.10 4,351,921
11/25/22 11.30 11.95 11.2501 11.89 778,695
11/23/22 11.72 11.86 11.09 11.36 958,169
11/22/22 11.80 11.80 10.9702 11.42 1,052,751
11/21/22 12.68 12.731 11.37 11.43 1,255,252
11/18/22 13.22 13.25 12.63 12.68 873,107
11/17/22 13.59 13.78 12.41 12.79 1,538,601
11/16/22 14.22 14.55 13.61 13.77 935,862
11/15/22 14.51 14.6719 13.97 14.05 1,025,247
11/14/22 14.60 15.24 14.08 14.11 1,561,679
11/11/22 13.50 14.7281 13.50 14.43 1,356,107
11/10/22 12.30 13.55 12.2706 13.40 1,780,100
11/09/22 12.00 12.29 11.75 11.79 827,695
11/08/22 11.55 12.48 11.49 12.17 873,768
11/07/22 11.86 11.99 11.42 11.49 675,775
11/04/22 11.85 11.85 11.13 11.73 795,818
11/03/22 11.66 12.01 11.5355 11.72 533,945
11/02/22 12.40 12.74 11.76 11.78 770,621
11/01/22 12.34 12.57 12.09 12.40 685,309
10/31/22 12.22 12.435 12.06 12.17 634,003
10/28/22 11.71 12.325 11.51 12.26 742,387
10/27/22 12.09 12.18 11.56 11.68 631,226
10/26/22 11.75 12.51 11.70 11.92 884,710
10/25/22 11.89 12.34 11.80 11.87 740,850
10/24/22 12.12 12.12 11.50 11.77 824,526
10/21/22 11.22 12.02 11.0754 11.95 917,396
10/20/22 11.10 11.4803 11.025 11.15 685,604
10/19/22 12.13 12.27 11.045 11.20 1,365,248
10/18/22 13.00 13.34 12.2109 12.29 1,484,724
10/17/22 11.07 12.62 11.06 12.49 1,957,270
10/14/22 10.96 11.11 10.5287 10.60 665,148
10/13/22 10.28 10.99 10.06 10.97 786,767
10/12/22 11.00 11.17 10.39 10.57 604,795
10/11/22 10.30 11.26 10.1577 10.87 928,422
10/10/22 10.41 10.52 10.20 10.33 530,998
10/07/22 10.86 11.05 10.48 10.51 803,289
10/06/22 10.71 11.15 10.586 11.03 641,298
10/05/22 10.70 10.91 10.445 10.81 551,359
10/04/22 10.68 10.90 10.455 10.89 872,662
10/03/22 10.59 10.72 10.24 10.49 819,381
09/30/22 9.55 10.66 9.55 10.32 1,047,419
09/29/22 10.15 10.44 9.65 9.75 1,085,396
09/28/22 9.55 10.60 9.36 10.45 1,621,396
09/27/22 9.06 9.36 8.93 9.25 856,393
09/26/22 9.09 9.49 8.87 8.90 665,760
09/23/22 9.28 9.3745 8.91 9.18 864,282
09/22/22 9.12 9.51 8.90 9.34 789,342
09/21/22 9.58 9.68 9.1646 9.20 860,995
09/20/22 8.98 9.27 8.96 9.20 709,251
09/19/22 9.13 9.32 8.90 9.08 651,342
09/16/22 9.34 9.40 8.97 9.25 1,177,285
09/15/22 9.50 9.68 9.26 9.51 596,019
09/14/22 9.45 9.87 9.31 9.62 718,129
09/13/22 9.50 9.74 9.31 9.41 847,938
09/12/22 10.32 10.33 9.815 9.93 837,412
09/09/22 10.02 10.39 9.935 10.30 555,798
09/08/22 9.42 10.03 9.34 9.97 596,021
09/07/22 9.01 9.595 9.01 9.57 926,366
09/06/22 9.43 9.43 8.93 8.97 827,012
09/02/22 9.80 9.80 9.19 9.22 527,280
09/01/22 9.51 9.68 9.25 9.65 417,858
08/31/22 9.70 9.93 9.46 9.59 770,318
08/30/22 9.99 10.08 9.33 9.53 667,769
08/29/22 9.52 9.99 9.49 9.75 522,825
08/26/22 10.50 10.50 9.59 9.69 874,883
08/25/22 10.37 10.615 10.09 10.57 591,389
08/24/22 10.13 10.59 10.05 10.24 707,913
08/23/22 10.00 10.29 9.89 10.16 676,303
08/22/22 9.98 10.28 9.81 9.91 569,426
08/19/22 10.38 10.43 9.96 10.08 898,950
08/18/22 11.03 11.14 10.47 10.58 894,312
08/17/22 11.25 11.49 10.98 11.06 579,189
08/16/22 11.75 11.78 11.09 11.44 751,716
08/15/22 11.64 11.97 11.5388 11.87 599,609
08/12/22 11.11 11.65 11.11 11.65 683,893
08/11/22 11.67 11.96 10.96 10.99 793,822
08/10/22 11.13 11.67 11.045 11.67 742,078
08/09/22 10.91 11.25 10.55 10.80 855,310
08/08/22 11.60 11.865 11.25 11.45 882,548
08/05/22 10.61 11.66 10.40 11.66 928,157
08/04/22 10.56 10.90 10.36 10.83 754,714
08/03/22 10.56 10.88 10.33 10.53 628,420
08/02/22 9.77 10.408 9.65 10.34 696,209
08/01/22 10.76 10.87 9.80 9.88 1,097,873
07/29/22 10.52 10.5708 9.96 10.26 836,742
07/28/22 10.77 10.90 10.30 10.63 610,682
07/27/22 11.07 11.09 10.47 10.76 779,781
07/26/22 10.98 11.28 10.77 10.79 572,228
07/25/22 11.21 11.455 10.89 11.06 518,698
07/22/22 11.91 11.9683 11.16 11.17 657,712
07/21/22 11.48 11.935 11.39 11.88 537,796
07/20/22 11.18 12.00 11.135 11.47 936,154
07/19/22 10.86 11.5988 10.49 11.20 1,255,802
07/18/22 12.97 13.389 10.51 10.60 1,878,470
07/15/22 13.06 13.20 12.57 12.70 917,075
07/14/22 12.44 12.958 12.22 12.86 1,037,990
07/13/22 11.91 12.7699 11.57 12.63 702,937
07/12/22 12.22 12.56 11.57 12.31 784,001
07/11/22 12.81 12.95 12.10 12.17 750,475
07/08/22 12.21 12.82 12.17 12.78 731,488
07/07/22 12.01 13.10 11.95 12.55 1,342,863
07/06/22 11.08 11.99 11.00 11.91 1,177,749
07/05/22 10.33 11.05 10.10 11.04 1,119,486
07/01/22 10.01 10.33 9.93 10.30 635,572
06/30/22 9.68 10.20 9.56 10.01 723,078
06/29/22 9.86 9.94 9.59 9.89 446,346
06/28/22 10.18 10.25 9.71 9.91 695,471
06/27/22 10.20 10.31 9.97 10.09 651,773
06/24/22 10.56 10.66 9.78 10.17 1,228,409
06/23/22 9.85 10.485 9.80 10.45 1,646,345
06/22/22 8.82 9.62 8.78 9.46 730,784
06/21/22 8.75 9.5578 8.71 9.09 1,075,446
06/17/22 7.83 8.75 7.8101 8.47 3,578,511
06/16/22 7.68 7.88 7.38 7.72 1,149,045
06/15/22 7.67 8.189 7.58 8.10 929,661
06/14/22 7.63 7.76 7.36 7.54 828,559
06/13/22 7.88 7.88 7.40 7.55 1,200,131
06/10/22 8.35 8.475 7.97 8.10 849,748
06/09/22 8.95 9.07 8.52 8.54 621,942
06/08/22 8.80 9.32 8.80 9.04 677,498
06/07/22 8.17 8.93 8.1201 8.91 687,407
06/06/22 8.74 8.88 8.17 8.26 601,890
06/03/22 8.34 8.89 8.32 8.58 938,920
06/02/22 8.24 8.525 8.11 8.37 639,100
06/01/22 9.21 9.33 8.13 8.24 1,070,682
05/31/22 9.36 9.795 8.94 9.11 1,204,034
05/27/22 9.10 9.77 8.84 9.71 995,460
05/26/22 9.12 9.36 9.0106 9.06 461,256
05/25/22 9.02 9.19 8.79 9.10 718,916
05/24/22 9.12 9.21 8.66 9.04 675,098
05/23/22 9.32 9.79 9.15 9.27 581,528
05/20/22 9.38 9.66 8.939 9.62 857,874
05/19/22 8.69 9.39 8.69 9.27 960,069
05/18/22 8.98 9.24 8.51 8.72 955,010
05/17/22 8.82 9.435 8.82 9.43 855,858
05/16/22 8.52 9.12 8.44 8.72 630,674
05/13/22 7.99 8.68 7.955 8.59 856,316
05/12/22 7.14 8.22 7.13 7.75 1,230,853
05/11/22 7.69 8.16 7.229 7.31 1,424,913
05/10/22 8.15 8.50 7.285 7.69 1,347,336
05/09/22 8.05 8.39 7.38 7.59 1,481,892
05/06/22 8.86 8.86 8.26 8.35 997,140
05/05/22 9.56 9.71 8.77 9.03 816,323
05/04/22 9.25 9.835 8.89 9.76 759,934
05/03/22 9.09 9.33 9.00 9.26 535,242
05/02/22 8.56 9.05 8.55 9.05 1,068,028
04/29/22 8.90 9.2958 8.57 8.59 719,718
04/28/22 9.10 9.135 8.50 8.99 741,363
04/27/22 9.07 9.37 8.88 8.92 633,748
04/26/22 9.60 9.78 9.03 9.03 1,112,336
04/25/22 9.54 9.7713 9.42 9.67 598,011
04/22/22 9.84 10.15 9.61 9.63 834,584
04/21/22 10.61 10.6441 9.86 9.88 858,497
04/20/22 10.75 10.79 10.40 10.44 625,542
04/19/22 10.56 10.89 10.39 10.73 581,695
04/18/22 11.12 11.12 10.47 10.51 933,282
04/14/22 11.64 11.68 11.08 11.10 547,037
04/13/22 11.27 11.77 11.27 11.67 711,227
04/12/22 11.54 11.90 11.115 11.26 577,154
04/11/22 11.58 11.8763 11.28 11.33 654,077
04/08/22 11.95 12.19 11.702 11.80 578,035
04/07/22 12.28 12.46 11.751 11.98 585,552
04/06/22 12.13 12.425 11.82 12.30 933,517
04/05/22 12.85 12.85 11.99 12.04 955,107
04/04/22 12.70 13.00 12.55 12.84 766,321
04/01/22 12.39 12.77 12.33 12.64 737,118
03/31/22 12.36 12.685 12.28 12.31 699,713
03/30/22 12.88 13.08 12.21 12.27 748,568
03/29/22 12.78 13.10 12.73 12.93 1,030,437
03/28/22 12.52 12.77 12.32 12.60 592,068
03/25/22 12.85 12.91 12.45 12.48 666,647
03/24/22 12.55 12.89 12.20 12.73 754,466
03/23/22 12.70 13.14 12.40 12.41 1,057,919
03/22/22 12.66 13.01 12.5606 12.88 854,297
03/21/22 12.89 13.08 12.42 12.54 1,041,195
03/18/22 12.41 13.39 12.41 13.10 3,267,529
03/17/22 11.50 12.48 11.465 12.47 936,654
03/16/22 10.82 11.70 10.76 11.70 1,165,505
03/15/22 10.12 10.76 10.12 10.65 1,202,126
03/14/22 10.97 11.14 9.99 10.08 1,048,080
03/11/22 11.26 11.35 10.96 10.97 970,143
03/10/22 10.90 11.35 10.77 11.19 711,456
03/09/22 10.695 11.30 10.4401 11.19 1,124,725
03/08/22 10.16 10.74 9.89 10.22 914,816
03/07/22 10.28 10.63 10.12 10.15 722,386
03/04/22 10.53 10.82 10.27 10.37 665,802
03/03/22 10.88 10.98 10.42 10.63 749,380
03/02/22 10.67 11.00 10.61 10.78 692,634
Roughly 6.5 million...
There are two numbers with Medved Trader. The second, lower number is usually zero until updated after market. Today the 6.5 million number is showing. The number showing at close is usually different from the cut and paste but proves to be accurate in the long run.
One and two million days aren't that unsusual, but I used three million as a threshold. I would love for someone to explain this....
03/15/24 5.09 5.28 5.08 5.105 6,590,753
03/15/24 5.09 5.28 5.08 5.105 340,396
03/14/24 5.34 5.36 5.09 5.14 1,249,399
03/13/24 5.27 5.5732 5.185 5.38 1,302,716
03/12/24 5.21 5.30 5.08 5.20 1,151,309
03/11/24 5.43 5.515 5.1603 5.19 1,446,321
03/08/24 5.23 5.48 5.2221 5.45 1,139,994
03/07/24 5.10 5.34 5.03 5.19 1,393,902
03/06/24 5.08 5.11 4.96 5.02 1,213,041
03/05/24 5.05 5.15 4.96 4.98 913,480
03/04/24 5.33 5.35 4.985 5.11 1,003,137
03/01/24 5.19 5.4187 5.125 5.28 990,157
02/29/24 5.43 5.5076 5.115 5.14 1,003,136
02/28/24 5.26 5.3962 5.21 5.30 811,516
02/27/24 5.02 5.37 4.95 5.33 1,583,899
02/26/24 4.95 5.05 4.795 4.98 1,609,290
02/23/24 5.00 5.14 4.87 4.92 1,612,166
02/22/24 5.07 5.1199 4.95 5.01 1,862,210
02/21/24 5.38 5.44 5.04 5.08 1,360,342
02/20/24 5.60 5.665 5.32 5.36 1,083,108
02/16/24 5.74 5.82 5.63 5.67 785,961
02/15/24 5.88 5.97 5.64 5.83 862,044
02/14/24 5.68 5.91 5.5501 5.84 706,914
02/13/24 5.94 5.95 5.52 5.575 1,175,427
02/12/24 5.82 6.15 5.8108 6.14 972,878
02/09/24 5.77 5.8301 5.65 5.78 830,613
02/08/24 5.66 5.80 5.53 5.69 1,129,527
02/07/24 5.94 6.02 5.47 5.59 1,558,122
02/06/24 5.31 5.79 5.30 5.79 1,580,378
02/05/24 5.69 5.71 5.29 5.36 1,814,262
02/02/24 6.04 6.11 5.7031 5.73 1,625,577
02/01/24 6.00 6.15 5.87 6.15 810,153
01/31/24 6.27 6.361 5.97 5.97 1,046,260
01/30/24 6.67 6.67 6.29 6.29 1,027,371
01/29/24 6.34 6.819 6.25 6.75 976,884
01/26/24 6.73 6.8989 6.31 6.33 1,022,525
01/25/24 6.58 6.729 6.48 6.64 771,657
01/24/24 6.73 6.83 6.57 6.58 849,865
01/23/24 6.70 6.80 6.47 6.60 738,712
01/22/24 6.09 6.62 6.09 6.60 1,334,425
01/19/24 6.01 6.10 5.8002 6.05 1,209,988
01/18/24 6.10 6.10 5.90 6.01 730,082
01/17/24 5.87 6.065 5.75 6.05 791,382
01/16/24 5.96 6.011 5.785 5.98 1,276,698
01/12/24 6.03 6.20 5.91 5.99 1,365,632
01/11/24 6.20 6.20 5.95 6.01 1,565,453
01/10/24 6.40 6.54 6.19 6.25 1,163,170
01/09/24 6.46 6.535 6.34 6.41 1,115,047
01/08/24 5.94 6.56 5.83 6.56 2,041,916
01/05/24 6.15 6.18 5.9401 6.01 2,444,235
01/04/24 6.59 6.85 6.21 6.29 2,533,235
01/03/24 6.09 6.9315 6.00 6.53 3,362,978
01/02/24 5.90 6.95 5.79 6.045 9,264,803
12/29/23 9.58 9.58 9.26 9.31 1,014,673
12/28/23 9.91 10.066 9.44 9.60 1,269,351
12/27/23 9.42 9.91 9.36 9.91 1,380,072
12/26/23 9.08 9.4799 8.94 9.38 1,240,488
12/22/23 8.83 9.40 8.80 8.95 1,267,955
12/21/23 9.325 9.3409 8.50 8.75 1,977,454
12/20/23 9.95 10.21 8.75 8.85 2,574,989
12/19/23 9.00 10.45 8.9307 9.95 4,297,183
12/18/23 8.95 9.13 8.6994 8.79 1,007,676
12/15/23 8.87 9.00 8.69 8.84 1,813,185
12/14/23 8.60 8.90 8.60 8.78 1,331,289
12/13/23 7.90 8.45 7.84 8.45 1,138,570
12/12/23 7.85 8.03 7.79 7.89 851,847
12/11/23 8.01 8.02 7.66 7.91 711,916
12/08/23 8.12 8.24 7.93 7.96 694,745
12/07/23 8.02 8.19 7.92 8.13 815,007
12/06/23 8.09 8.19 7.915 8.01 834,826
12/05/23 8.15 8.17 7.93 7.95 965,659
12/04/23 7.61 8.32 7.58 8.20 1,337,229
12/01/23 7.15 7.62 7.01 7.57 1,070,483
11/30/23 7.27 7.42 7.0719 7.21 1,182,373
11/29/23 6.88 7.23 6.83 7.09 1,148,592
11/28/23 6.53 6.86 6.29 6.78 860,438
11/27/23 6.85 7.00 6.18 6.36 2,262,983
11/24/23 6.85 7.2494 6.81 7.07 676,612
11/22/23 6.76 6.8869 6.535 6.70 948,214
11/21/23 6.9995 7.54 6.70 6.72 2,403,049
11/20/23 7.00 7.0747 6.62 7.00 2,155,816
11/17/23 6.09 6.33 6.011 6.27 760,821
11/16/23 6.22 6.22 5.8746 6.01 866,093
11/15/23 6.25 6.54 6.17 6.18 946,968
11/14/23 6.04 6.24 5.98 6.22 1,182,876
11/13/23 5.63 5.77 5.47 5.75 712,183
11/10/23 5.80 5.83 5.55 5.74 733,258
11/09/23 5.98 6.01 5.65 5.71 1,210,742
11/08/23 6.21 6.27 5.87 5.97 1,150,794
11/07/23 5.97 6.23 5.87 6.21 1,360,828
11/06/23 6.02 6.14 5.84 5.93 773,838
11/03/23 5.71 6.18 5.60 6.04 1,255,000
11/02/23 5.62 5.78 5.525 5.69 891,245
11/01/23 5.57 5.69 5.455 5.62 620,479
10/31/23 5.45 5.645 5.32 5.58 744,195
10/30/23 5.19 5.55 5.19 5.50 722,704
10/27/23 5.65 5.78 5.175 5.20 1,014,042
10/26/23 5.62 5.91 5.48 5.62 1,107,385
10/25/23 5.17 5.70 5.04 5.59 1,747,445
10/24/23 5.15 5.36 4.98 5.13 1,281,654
10/23/23 5.14 5.2395 4.90 5.04 1,261,674
10/20/23 5.61 5.6599 5.16 5.20 1,600,626
10/19/23 5.66 5.69 5.53 5.59 556,951
10/18/23 5.94 5.95 5.61 5.65 657,528
10/17/23 6.02 6.19 5.99 5.99 597,555
10/16/23 6.05 6.13 5.9131 6.06 490,642
10/13/23 5.89 6.22 5.80 6.05 790,758
10/12/23 6.19 6.25 5.84 5.89 900,042
10/11/23 6.33 6.43 6.145 6.19 496,351
10/10/23 6.09 6.375 5.92 6.32 745,722
10/09/23 6.05 6.14 5.975 6.14 655,911
10/06/23 6.36 6.39 6.11 6.14 698,958
10/05/23 6.34 6.49 6.295 6.41 618,507
10/04/23 6.23 6.395 6.1702 6.35 693,209
10/03/23 6.30 6.325 6.095 6.26 836,713
10/02/23 6.57 6.63 6.29 6.36 828,452
09/29/23 6.81 6.85 6.515 6.55 898,145
09/28/23 6.81 6.82 6.60 6.72 607,717
09/27/23 6.83 6.95 6.665 6.81 547,953
09/26/23 6.74 7.04 6.74 6.80 606,126
09/25/23 6.85 6.9101 6.7499 6.79 549,032
09/22/23 7.00 7.00 6.84 6.89 668,733
09/21/23 7.13 7.20 6.86 6.97 768,865
09/20/23 7.12 7.92 7.07 7.24 1,467,088
09/19/23 7.12 7.13 6.81 7.12 1,119,280
09/18/23 7.79 7.84 7.065 7.13 1,660,138
09/15/23 8.00 8.0299 7.55 7.57 2,941,032
09/14/23 7.98 8.3899 7.57 7.95 2,770,282
09/13/23 7.73 8.02 7.64 7.66 738,376
09/12/23 7.75 7.85 7.67 7.75 656,619
09/11/23 7.87 7.90 7.65 7.75 626,961
09/08/23 7.72 7.88 7.64 7.87 653,361
09/07/23 7.75 7.83 7.68 7.71 798,330
09/06/23 7.84 7.89 7.71 7.81 672,631
09/05/23 7.92 8.02 7.80 7.87 573,983
09/01/23 7.92 8.09 7.875 7.94 574,135
08/31/23 7.90 8.02 7.80 7.90 715,021
08/30/23 7.94 8.02 7.8219 7.92 536,305
08/29/23 7.91 7.98 7.765 7.95 598,769
08/28/23 8.07 8.15 7.874 7.93 409,031
08/25/23 7.86 8.08 7.7626 8.04 603,374
08/24/23 8.03 8.08 7.595 7.75 1,000,793
08/23/23 8.18 8.23 8.00 8.02 400,281
08/22/23 8.21 8.28 8.01 8.14 492,302
08/21/23 8.16 8.3201 8.01 8.17 614,083
08/18/23 8.01 8.33 7.97 8.16 467,810
08/17/23 8.60 8.75 8.10 8.12 961,832
08/16/23 8.88 8.885 8.62 8.62 667,419
08/15/23 9.06 9.07 8.69 8.94 677,315
08/14/23 8.75 9.15 8.61 9.15 710,441
08/11/23 8.94 9.01 8.68 8.82 571,306
08/10/23 9.30 9.89 8.94 9.05 1,983,246
08/09/23 8.13 9.46 8.08 9.37 3,091,301
08/08/23 8.00 8.07 7.5806 8.03 1,131,164
08/07/23 8.18 8.21 7.63 7.68 1,072,514
08/04/23 8.30 8.50 8.19 8.22 650,810
08/03/23 8.16 8.36 8.10 8.30 666,223
08/02/23 8.04 8.31 7.965 8.22 624,528
08/01/23 8.21 8.23 7.97 8.15 683,015
07/31/23 7.94 8.27 7.935 8.25 745,856
07/28/23 7.70 7.95 7.66 7.93 675,354
07/27/23 8.04 8.06 7.6201 7.66 1,040,508
07/26/23 8.03 8.10 7.95 7.99 481,492
07/25/23 8.14 8.22 7.93 8.02 547,522
07/24/23 7.91 8.21 7.91 8.17 718,754
07/21/23 8.08 8.17 7.92 8.11 778,051
07/20/23 8.25 8.29 7.9909 8.00 555,303
07/19/23 8.38 8.49 8.2916 8.33 426,044
07/18/23 8.40 8.57 8.365 8.38 426,909
07/17/23 8.41 8.56 8.27 8.37 1,006,859
07/14/23 8.46 8.54 8.34 8.42 484,542
07/13/23 8.57 8.62 8.43 8.45 398,155
07/12/23 8.71 8.71 8.4399 8.55 548,358
07/11/23 8.63 8.74 8.485 8.61 537,648
07/10/23 8.14 8.68 8.13 8.66 1,057,445
07/07/23 7.91 8.18 7.90 8.16 631,574
07/06/23 7.88 7.9175 7.73 7.88 646,955
07/05/23 8.01 8.03 7.80 7.95 755,540
07/03/23 8.13 8.1807 7.925 8.01 570,322
06/30/23 8.01 8.18 7.90 8.13 710,877
06/29/23 7.98 8.20 7.87 7.91 874,459
06/28/23 8.09 8.09 7.87 7.98 1,317,731
06/27/23 8.20 8.22 8.01 8.08 688,145
06/26/23 8.12 8.28 8.00 8.20 704,724
06/23/23 8.25 8.25 8.08 8.16 966,319
06/22/23 8.46 8.46 8.26 8.30 590,478
06/21/23 8.36 8.62 8.2201 8.52 608,483
06/20/23 8.53 8.58 8.30 8.41 963,674
06/16/23 8.95 8.96 8.41 8.57 4,097,261
06/15/23 8.76 8.94 8.58 8.83 849,112
06/14/23 8.85 8.935 8.59 8.75 796,239
06/13/23 8.75 8.99 8.51 8.83 884,454
06/12/23 9.20 9.36 8.49 8.655 1,656,815
06/09/23 9.28 10.17 8.91 9.15 3,982,144
06/08/23 9.39 9.4999 9.12 9.24 892,868
06/07/23 9.07 9.47 9.0143 9.38 920,716
06/06/23 9.11 9.215 8.94 9.11 715,458
06/05/23 9.05 9.23 9.03 9.07 702,343
06/02/23 9.17 9.24 8.915 9.14 811,391
06/01/23 9.22 9.34 9.05 9.10 653,851
05/31/23 9.18 9.47 9.00 9.24 683,974
05/30/23 9.45 9.50 9.07 9.18 651,131
05/26/23 8.97 9.355 8.945 9.32 960,729
05/25/23 9.22 9.26 8.88 8.96 711,682
05/24/23 9.17 9.27 9.055 9.21 762,299
05/23/23 9.44 9.7291 9.20 9.26 957,685
05/22/23 9.45 9.59 9.35 9.50 665,369
05/19/23 9.45 9.5299 9.27 9.45 547,935
05/18/23 9.50 9.50 9.03 9.29 734,732
05/17/23 9.09 9.51 8.94 9.50 801,084
05/16/23 9.36 9.38 8.87 9.01 954,695
05/15/23 9.14 9.66 9.07 9.49 884,281
05/12/23 9.26 9.32 8.88 9.10 533,527
05/11/23 9.37 9.45 9.03 9.19 860,401
05/10/23 9.32 9.6299 9.04 9.36 1,250,446
05/09/23 8.15 9.28 8.02 9.07 1,230,245
05/08/23 8.42 8.45 8.20 8.41 880,194
05/05/23 8.50 8.63 8.41 8.44 796,423
05/04/23 8.32 8.485 8.1101 8.40 798,618
05/03/23 8.05 8.50 8.03 8.34 1,268,245
05/02/23 8.28 8.39 7.95 8.00 994,335
05/01/23 8.15 8.27 7.98 8.22 853,997
04/28/23 8.20 8.23 8.05 8.14 692,861
04/27/23 8.31 8.3699 8.06 8.19 727,456
04/26/23 7.76 8.29 7.6601 8.24 1,237,862
04/25/23 7.81 7.88 7.65 7.77 697,888
04/24/23 8.01 8.04 7.68 7.85 621,921
04/21/23 7.97 8.08 7.93 8.03 642,162
04/20/23 8.15 8.15 7.93 7.97 857,550
04/19/23 8.06 8.28 8.00 8.19 605,459
04/18/23 8.16 8.16 7.99 8.12 703,699
04/17/23 7.95 8.26 7.8573 8.13 1,222,660
04/14/23 8.02 8.04 7.645 7.88 866,393
04/13/23 7.69 8.15 7.69 8.07 1,391,473
04/12/23 7.75 7.88 7.59 7.66 696,635
04/11/23 7.70 7.80 7.60 7.67 801,756
04/10/23 7.78 7.78 7.44 7.70 1,250,671
04/06/23 7.87 7.87 7.685 7.79 910,731
04/05/23 7.97 8.10 7.795 7.87 838,425
04/04/23 8.50 8.5113 7.9429 8.07 1,265,141
04/03/23 8.53 8.62 8.36 8.51 835,948
03/31/23 8.45 8.70 8.36 8.57 1,544,409
03/30/23 8.86 8.98 8.25 8.32 2,170,673
03/29/23 8.51 8.59 8.32 8.56 1,050,149
03/28/23 8.50 8.61 8.27 8.32 785,134
03/27/23 8.76 8.80 8.485 8.51 857,996
03/24/23 8.60 8.79 8.42 8.72 1,082,049
03/23/23 8.65 8.92 8.38 8.68 1,203,720
03/22/23 9.07 9.07 8.475 8.52 1,642,298
03/21/23 9.34 9.45 8.92 9.10 1,178,875
03/20/23 9.49 9.495 9.19 9.26 916,955
03/17/23 9.40 9.55 9.21 9.51 1,908,550
03/16/23 9.31 9.7201 9.05 9.54 1,020,423
03/15/23 9.25 9.51 9.15 9.36 1,471,135
03/14/23 9.63 9.86 9.21 9.53 1,323,462
03/13/23 8.59 9.4799 8.59 9.40 1,829,250
03/10/23 9.66 9.66 8.535 8.98 2,218,992
03/09/23 10.15 10.37 9.57 9.68 1,052,112
03/08/23 9.77 10.13 9.74 10.11 905,481
03/07/23 9.88 10.18 9.694 9.83 880,221
03/06/23 9.96 10.01 9.64 9.87 816,010
03/03/23 9.77 10.0475 9.59 9.93 866,174
03/02/23 9.50 9.74 9.37 9.67 745,240
03/01/23 9.52 9.735 9.44 9.68 836,694
02/28/23 9.68 9.82 9.47 9.52 810,555
02/27/23 9.79 9.86 9.565 9.65 747,731
02/24/23 9.80 9.83 9.60 9.72 856,992
02/23/23 10.15 10.18 9.84 9.93 768,802
02/22/23 10.03 10.22 9.99 10.11 756,675
02/21/23 10.38 10.45 9.97 10.00 1,127,474
02/17/23 10.41 10.58 10.25 10.58 747,457
02/16/23 10.33 10.60 10.25 10.42 1,004,762
02/15/23 10.48 10.625 10.285 10.47 745,972
02/14/23 10.43 10.72 10.27 10.60 917,743
02/13/23 10.55 10.671 10.40 10.50 727,780
02/10/23 10.39 10.63 10.18 10.54 777,576
02/09/23 11.04 11.10 10.40 10.41 1,177,320
02/08/23 11.51 11.90 10.9231 10.93 1,419,648
02/07/23 11.00 11.925 10.78 11.75 2,043,120
02/06/23 11.24 11.59 11.11 11.11 1,313,264
02/03/23 11.11 11.59 11.05 11.26 1,073,016
02/02/23 11.09 11.71 10.97 11.37 1,438,366
02/01/23 10.89 11.22 10.57 10.99 1,188,421
01/31/23 10.13 10.89 10.06 10.87 1,377,317
01/30/23 10.74 10.76 9.84 10.05 1,927,351
01/27/23 10.52 10.69 10.41 10.56 615,844
01/26/23 10.91 10.99 10.39 10.52 595,981
01/25/23 10.52 10.83 10.32 10.79 871,965
01/24/23 10.38 10.91 10.2221 10.72 1,157,931
01/23/23 10.33 10.58 10.13 10.47 971,023
01/20/23 10.22 10.41 9.98 10.30 981,763
01/19/23 9.99 10.24 9.65 10.10 1,116,567
01/18/23 10.56 10.75 10.055 10.13 1,206,547
01/17/23 10.50 10.63 10.21 10.46 1,621,981
01/13/23 11.05 11.335 10.15 10.58 2,105,408
01/12/23 10.86 11.24 10.38 11.21 1,923,905
01/11/23 10.39 10.82 10.10 10.80 1,483,107
01/10/23 9.83 10.39 9.775 10.39 1,170,341
01/09/23 10.14 10.17 9.57 9.85 1,121,519
01/06/23 10.02 10.20 9.68 10.00 1,543,951
01/05/23 9.91 9.97 9.46 9.87 1,126,940
01/04/23 9.74 10.09 9.46 9.97 1,366,576
01/03/23 9.89 9.89 9.32 9.68 1,769,013
12/30/22 9.00 9.26 8.91 9.26 1,088,616
12/29/22 8.29 9.28 8.20 9.13 1,862,813
12/28/22 8.11 8.34 8.01 8.19 1,011,516
12/27/22 8.45 8.55 8.13 8.16 1,206,733
12/23/22 8.60 8.69 8.22 8.45 850,624
12/22/22 8.60 8.69 8.2813 8.57 1,204,159
12/21/22 8.68 8.86 8.44 8.61 1,171,623
12/20/22 8.47 8.9084 8.36 8.71 1,094,310
12/19/22 8.65 8.685 8.175 8.51 1,634,836
12/16/22 8.27 8.695 8.185 8.64 3,155,206
12/15/22 8.70 8.80 8.30 8.35 1,537,386
12/14/22 8.68 8.98 8.50 8.83 1,319,980
12/13/22 8.94 9.049 8.37 8.74 1,780,898
12/12/22 7.75 8.85 7.73 8.67 3,394,869
12/09/22 7.99 8.07 7.63 7.65 2,292,232
12/08/22 8.50 8.5237 7.9501 8.08 2,635,981
12/07/22 8.34 9.10 8.31 8.49 2,737,453
12/06/22 9.21 9.2101 8.34 8.38 6,006,781
12/05/22 12.03 12.11 9.56 9.58 8,403,482
12/02/22 12.57 13.23 10.66 12.05 45,682,570
12/01/22 8.90 9.57 8.80 8.87 2,157,524
11/30/22 8.96 9.14 8.29 8.82 4,017,257
11/29/22 9.24 9.46 8.7701 8.94 2,155,419
11/28/22 12.46 12.49 8.865 9.10 4,351,921
11/25/22 11.30 11.95 11.2501 11.89 778,695
11/23/22 11.72 11.86 11.09 11.36 958,169
11/22/22 11.80 11.80 10.9702 11.42 1,052,751
11/21/22 12.68 12.731 11.37 11.43 1,255,252
11/18/22 13.22 13.25 12.63 12.68 873,107
11/17/22 13.59 13.78 12.41 12.79 1,538,601
11/16/22 14.22 14.55 13.61 13.77 935,862
11/15/22 14.51 14.6719 13.97 14.05 1,025,247
11/14/22 14.60 15.24 14.08 14.11 1,561,679
11/11/22 13.50 14.7281 13.50 14.43 1,356,107
11/10/22 12.30 13.55 12.2706 13.40 1,780,100
11/09/22 12.00 12.29 11.75 11.79 827,695
11/08/22 11.55 12.48 11.49 12.17 873,768
11/07/22 11.86 11.99 11.42 11.49 675,775
11/04/22 11.85 11.85 11.13 11.73 795,818
11/03/22 11.66 12.01 11.5355 11.72 533,945
11/02/22 12.40 12.74 11.76 11.78 770,621
11/01/22 12.34 12.57 12.09 12.40 685,309
10/31/22 12.22 12.435 12.06 12.17 634,003
10/28/22 11.71 12.325 11.51 12.26 742,387
10/27/22 12.09 12.18 11.56 11.68 631,226
10/26/22 11.75 12.51 11.70 11.92 884,710
10/25/22 11.89 12.34 11.80 11.87 740,850
10/24/22 12.12 12.12 11.50 11.77 824,526
10/21/22 11.22 12.02 11.0754 11.95 917,396
10/20/22 11.10 11.4803 11.025 11.15 685,604
10/19/22 12.13 12.27 11.045 11.20 1,365,248
10/18/22 13.00 13.34 12.2109 12.29 1,484,724
10/17/22 11.07 12.62 11.06 12.49 1,957,270
10/14/22 10.96 11.11 10.5287 10.60 665,148
10/13/22 10.28 10.99 10.06 10.97 786,767
10/12/22 11.00 11.17 10.39 10.57 604,795
10/11/22 10.30 11.26 10.1577 10.87 928,422
10/10/22 10.41 10.52 10.20 10.33 530,998
10/07/22 10.86 11.05 10.48 10.51 803,289
10/06/22 10.71 11.15 10.586 11.03 641,298
10/05/22 10.70 10.91 10.445 10.81 551,359
10/04/22 10.68 10.90 10.455 10.89 872,662
10/03/22 10.59 10.72 10.24 10.49 819,381
09/30/22 9.55 10.66 9.55 10.32 1,047,419
09/29/22 10.15 10.44 9.65 9.75 1,085,396
09/28/22 9.55 10.60 9.36 10.45 1,621,396
09/27/22 9.06 9.36 8.93 9.25 856,393
09/26/22 9.09 9.49 8.87 8.90 665,760
09/23/22 9.28 9.3745 8.91 9.18 864,282
09/22/22 9.12 9.51 8.90 9.34 789,342
09/21/22 9.58 9.68 9.1646 9.20 860,995
09/20/22 8.98 9.27 8.96 9.20 709,251
09/19/22 9.13 9.32 8.90 9.08 651,342
09/16/22 9.34 9.40 8.97 9.25 1,177,285
09/15/22 9.50 9.68 9.26 9.51 596,019
09/14/22 9.45 9.87 9.31 9.62 718,129
09/13/22 9.50 9.74 9.31 9.41 847,938
09/12/22 10.32 10.33 9.815 9.93 837,412
09/09/22 10.02 10.39 9.935 10.30 555,798
09/08/22 9.42 10.03 9.34 9.97 596,021
09/07/22 9.01 9.595 9.01 9.57 926,366
09/06/22 9.43 9.43 8.93 8.97 827,012
09/02/22 9.80 9.80 9.19 9.22 527,280
09/01/22 9.51 9.68 9.25 9.65 417,858
08/31/22 9.70 9.93 9.46 9.59 770,318
08/30/22 9.99 10.08 9.33 9.53 667,769
08/29/22 9.52 9.99 9.49 9.75 522,825
08/26/22 10.50 10.50 9.59 9.69 874,883
08/25/22 10.37 10.615 10.09 10.57 591,389
08/24/22 10.13 10.59 10.05 10.24 707,913
08/23/22 10.00 10.29 9.89 10.16 676,303
08/22/22 9.98 10.28 9.81 9.91 569,426
08/19/22 10.38 10.43 9.96 10.08 898,950
08/18/22 11.03 11.14 10.47 10.58 894,312
08/17/22 11.25 11.49 10.98 11.06 579,189
08/16/22 11.75 11.78 11.09 11.44 751,716
08/15/22 11.64 11.97 11.5388 11.87 599,609
08/12/22 11.11 11.65 11.11 11.65 683,893
08/11/22 11.67 11.96 10.96 10.99 793,822
08/10/22 11.13 11.67 11.045 11.67 742,078
08/09/22 10.91 11.25 10.55 10.80 855,310
08/08/22 11.60 11.865 11.25 11.45 882,548
08/05/22 10.61 11.66 10.40 11.66 928,157
08/04/22 10.56 10.90 10.36 10.83 754,714
08/03/22 10.56 10.88 10.33 10.53 628,420
08/02/22 9.77 10.408 9.65 10.34 696,209
08/01/22 10.76 10.87 9.80 9.88 1,097,873
07/29/22 10.52 10.5708 9.96 10.26 836,742
07/28/22 10.77 10.90 10.30 10.63 610,682
07/27/22 11.07 11.09 10.47 10.76 779,781
07/26/22 10.98 11.28 10.77 10.79 572,228
07/25/22 11.21 11.455 10.89 11.06 518,698
07/22/22 11.91 11.9683 11.16 11.17 657,712
07/21/22 11.48 11.935 11.39 11.88 537,796
07/20/22 11.18 12.00 11.135 11.47 936,154
07/19/22 10.86 11.5988 10.49 11.20 1,255,802
07/18/22 12.97 13.389 10.51 10.60 1,878,470
07/15/22 13.06 13.20 12.57 12.70 917,075
07/14/22 12.44 12.958 12.22 12.86 1,037,990
07/13/22 11.91 12.7699 11.57 12.63 702,937
07/12/22 12.22 12.56 11.57 12.31 784,001
07/11/22 12.81 12.95 12.10 12.17 750,475
07/08/22 12.21 12.82 12.17 12.78 731,488
07/07/22 12.01 13.10 11.95 12.55 1,342,863
07/06/22 11.08 11.99 11.00 11.91 1,177,749
07/05/22 10.33 11.05 10.10 11.04 1,119,486
07/01/22 10.01 10.33 9.93 10.30 635,572
06/30/22 9.68 10.20 9.56 10.01 723,078
06/29/22 9.86 9.94 9.59 9.89 446,346
06/28/22 10.18 10.25 9.71 9.91 695,471
06/27/22 10.20 10.31 9.97 10.09 651,773
06/24/22 10.56 10.66 9.78 10.17 1,228,409
06/23/22 9.85 10.485 9.80 10.45 1,646,345
06/22/22 8.82 9.62 8.78 9.46 730,784
06/21/22 8.75 9.5578 8.71 9.09 1,075,446
06/17/22 7.83 8.75 7.8101 8.47 3,578,511
06/16/22 7.68 7.88 7.38 7.72 1,149,045
06/15/22 7.67 8.189 7.58 8.10 929,661
06/14/22 7.63 7.76 7.36 7.54 828,559
06/13/22 7.88 7.88 7.40 7.55 1,200,131
06/10/22 8.35 8.475 7.97 8.10 849,748
06/09/22 8.95 9.07 8.52 8.54 621,942
06/08/22 8.80 9.32 8.80 9.04 677,498
06/07/22 8.17 8.93 8.1201 8.91 687,407
06/06/22 8.74 8.88 8.17 8.26 601,890
06/03/22 8.34 8.89 8.32 8.58 938,920
06/02/22 8.24 8.525 8.11 8.37 639,100
06/01/22 9.21 9.33 8.13 8.24 1,070,682
05/31/22 9.36 9.795 8.94 9.11 1,204,034
05/27/22 9.10 9.77 8.84 9.71 995,460
05/26/22 9.12 9.36 9.0106 9.06 461,256
05/25/22 9.02 9.19 8.79 9.10 718,916
05/24/22 9.12 9.21 8.66 9.04 675,098
05/23/22 9.32 9.79 9.15 9.27 581,528
05/20/22 9.38 9.66 8.939 9.62 857,874
05/19/22 8.69 9.39 8.69 9.27 960,069
05/18/22 8.98 9.24 8.51 8.72 955,010
05/17/22 8.82 9.435 8.82 9.43 855,858
05/16/22 8.52 9.12 8.44 8.72 630,674
05/13/22 7.99 8.68 7.955 8.59 856,316
05/12/22 7.14 8.22 7.13 7.75 1,230,853
05/11/22 7.69 8.16 7.229 7.31 1,424,913
05/10/22 8.15 8.50 7.285 7.69 1,347,336
05/09/22 8.05 8.39 7.38 7.59 1,481,892
05/06/22 8.86 8.86 8.26 8.35 997,140
05/05/22 9.56 9.71 8.77 9.03 816,323
05/04/22 9.25 9.835 8.89 9.76 759,934
05/03/22 9.09 9.33 9.00 9.26 535,242
05/02/22 8.56 9.05 8.55 9.05 1,068,028
04/29/22 8.90 9.2958 8.57 8.59 719,718
04/28/22 9.10 9.135 8.50 8.99 741,363
04/27/22 9.07 9.37 8.88 8.92 633,748
04/26/22 9.60 9.78 9.03 9.03 1,112,336
04/25/22 9.54 9.7713 9.42 9.67 598,011
04/22/22 9.84 10.15 9.61 9.63 834,584
04/21/22 10.61 10.6441 9.86 9.88 858,497
04/20/22 10.75 10.79 10.40 10.44 625,542
04/19/22 10.56 10.89 10.39 10.73 581,695
04/18/22 11.12 11.12 10.47 10.51 933,282
04/14/22 11.64 11.68 11.08 11.10 547,037
04/13/22 11.27 11.77 11.27 11.67 711,227
04/12/22 11.54 11.90 11.115 11.26 577,154
04/11/22 11.58 11.8763 11.28 11.33 654,077
04/08/22 11.95 12.19 11.702 11.80 578,035
04/07/22 12.28 12.46 11.751 11.98 585,552
04/06/22 12.13 12.425 11.82 12.30 933,517
04/05/22 12.85 12.85 11.99 12.04 955,107
04/04/22 12.70 13.00 12.55 12.84 766,321
04/01/22 12.39 12.77 12.33 12.64 737,118
03/31/22 12.36 12.685 12.28 12.31 699,713
03/30/22 12.88 13.08 12.21 12.27 748,568
03/29/22 12.78 13.10 12.73 12.93 1,030,437
03/28/22 12.52 12.77 12.32 12.60 592,068
03/25/22 12.85 12.91 12.45 12.48 666,647
03/24/22 12.55 12.89 12.20 12.73 754,466
03/23/22 12.70 13.14 12.40 12.41 1,057,919
03/22/22 12.66 13.01 12.5606 12.88 854,297
03/21/22 12.89 13.08 12.42 12.54 1,041,195
03/18/22 12.41 13.39 12.41 13.10 3,267,529
03/17/22 11.50 12.48 11.465 12.47 936,654
03/16/22 10.82 11.70 10.76 11.70 1,165,505
03/15/22 10.12 10.76 10.12 10.65 1,202,126
03/14/22 10.97 11.14 9.99 10.08 1,048,080
03/11/22 11.26 11.35 10.96 10.97 970,143
03/10/22 10.90 11.35 10.77 11.19 711,456
03/09/22 10.695 11.30 10.4401 11.19 1,124,725
03/08/22 10.16 10.74 9.89 10.22 914,816
03/07/22 10.28 10.63 10.12 10.15 722,386
03/04/22 10.53 10.82 10.27 10.37 665,802
03/03/22 10.88 10.98 10.42 10.63 749,380
03/02/22 10.67 11.00 10.61 10.78 692,634
LWLG Blocks >=1K
see replied to post for earlier data
03/15/24 16:05:03 4.0903 4.04 4.10 1,500
03/15/24 16:04:01 4.09 4.04 4.10 9,300
03/15/24 16:03:49 4.09 4.04 4.10 47,000
03/15/24 16:03:36 4.09 4.04 4.10 3,600
03/15/24 16:03:24 4.09 4.04 4.27 3,800
03/15/24 16:03:08 4.09 4.04 4.40 2,100
03/15/24 16:00:05 4.10 4.07 4.12 8,453
03/15/24 16:00:03 4.10 4.07 4.12 1,444
03/15/24 16:00:00 4.10 4.09 4.12 246,337
03/15/24 15:59:56 4.10 4.10 4.10 3,103
03/15/24 15:59:52 4.10 4.10 4.11 3,617
03/15/24 15:59:38 4.08 4.09 4.10 1,279
03/15/24 15:59:36 4.08 4.09 4.10 6,351
03/15/24 15:59:34 4.08 4.09 4.10 5,180
03/15/24 15:59:32 4.08 4.08 4.09 2,087
03/15/24 15:59:15 4.07 4.07 4.08 2,687
03/15/24 15:57:19 4.074 4.07 4.08 1,000
03/15/24 15:55:14 4.09 4.09 4.10 3,014
03/15/24 15:54:02 4.0697 4.06 4.07 1,900
03/15/24 15:52:00 4.07 4.06 4.07 1,592
03/15/24 15:50:33 4.03 4.05 4.06 4,302
03/15/24 15:50:32 4.03 4.05 4.06 4,324
03/15/24 15:50:01 4.03 4.03 4.04 1,200
03/15/24 15:50:01 4.03 4.03 4.04 1,000
03/15/24 15:50:01 4.03 4.03 4.04 1,000
03/15/24 15:50:01 4.035 4.03 4.04 1,243
03/15/24 15:50:00 4.035 4.03 4.04 6,481
03/15/24 15:49:03 4.0301 4.03 4.04 5,000
03/15/24 15:43:54 4.05 4.05 4.06 1,900
03/15/24 15:34:29 4.05 4.05 4.06 2,500
03/15/24 15:19:12 4.0708 4.07 4.08 3,300
03/15/24 15:18:55 4.075 4.07 4.08 1,195
03/15/24 15:17:15 4.08 4.08 4.09 1,060
03/15/24 15:16:21 4.08 4.08 4.09 5,100
03/15/24 15:13:26 4.095 4.09 4.10 1,000
03/15/24 15:11:05 4.1001 4.10 4.11 1,000
03/15/24 14:47:55 4.0797 4.07 4.08 1,000
03/15/24 14:47:23 4.08 4.08 4.09 1,300
03/15/24 14:35:11 4.0797 4.07 4.08 1,000
03/15/24 14:19:22 4.0801 4.08 4.09 4,800
03/15/24 13:38:24 4.1015 4.10 4.11 1,000
03/15/24 13:35:40 4.105 4.10 4.11 1,000
03/15/24 12:53:51 4.095 4.09 4.10 1,100
03/15/24 12:25:46 4.115 4.11 4.12 1,000
03/15/24 12:01:54 4.135 4.13 4.14 3,000
03/15/24 11:59:21 4.1323 4.13 4.14 2,000
03/15/24 11:59:15 4.1301 4.13 4.14 1,800
03/15/24 11:38:13 4.13 4.13 4.14 1,213
03/15/24 11:35:00 4.13 4.13 4.14 1,157
03/15/24 11:30:49 4.1293 4.12 4.13 1,300
03/15/24 11:23:54 4.11 4.11 4.12 1,900
03/15/24 11:23:54 4.11 4.11 4.12 1,900
03/15/24 11:22:24 4.1109 4.11 4.12 3,000
03/15/24 11:19:59 4.1109 4.11 4.12 2,000
03/15/24 11:19:02 4.1109 4.11 4.12 1,600
03/15/24 11:13:46 4.1215 4.12 4.13 1,200
03/15/24 10:58:40 4.125 4.12 4.13 1,000
03/15/24 10:58:27 4.125 4.12 4.13 1,600
03/15/24 10:54:01 4.1303 4.13 4.14 4,000
03/15/24 10:49:43 4.13 4.12 4.13 2,000
03/15/24 10:29:35 4.095 4.09 4.10 1,000
03/15/24 10:18:43 4.115 4.11 4.12 1,000
03/15/24 10:18:01 4.1105 4.11 4.12 2,000
03/15/24 10:16:42 4.1173 4.11 4.12 1,000
03/15/24 10:14:12 4.10 4.09 4.10 2,400
03/15/24 10:10:25 4.07 4.07 4.08 2,000
03/15/24 10:10:22 4.07 4.07 4.08 2,000
03/15/24 10:08:41 4.065 4.06 4.07 1,000
03/15/24 10:07:02 4.05 4.04 4.05 1,000
03/15/24 10:07:02 4.05 4.04 4.05 1,300
03/15/24 10:05:07 4.06 4.05 4.06 1,300
03/15/24 09:59:26 4.05 4.03 4.05 4,000
03/15/24 09:56:16 4.045 4.04 4.05 2,000
03/15/24 09:53:29 4.035 4.03 4.04 1,200
03/15/24 09:49:16 4.02 4.02 4.03 1,395
03/15/24 09:48:48 4.0206 4.02 4.03 1,000
03/15/24 09:46:01 4.02 4.02 4.03 1,300
03/15/24 09:43:18 4.02 4.02 4.03 1,100
03/15/24 09:42:50 4.02 4.02 4.03 1,100
03/15/24 09:42:50 4.02 4.02 4.03 1,100
03/15/24 09:30:00 3.95 3.97 4.46 171,200
Why didn't you specifically quote those specific accusations??????
OK - feeling very optimistic about Lightwave today. Lots of new info on the LWLG board so I'm expecting to see some short covering soon.
I ran across this company today which also seems to be very intriguing. Fourth quarter financials came out today.
Lots to look at here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174047278
Product Performance
Desktop Metal and Evonik expand partnership, announce qualification of INFINAM® ST 6100 L on large format Additive Manufacturing 2.0 systems for high-performance, high-temperature products
Desktop Health™ announces Flexcera™ Base Ultra+ dental resin for stronger, more comfortable 3D Printed dentures
Desktop Metal now shipping the Figur G15 – a Digital Sheet Metal Forming machine that eliminates the need for custom tooling
Desktop Health announces first patients treated with FDA-Cleared CMFlex™ – and off-the-shelf 3D printed synthetic bone graft product pioneered by Dimension Inx on the 3D-Bioplotter®
Desktop Metal launches Live Monitor™ for users of Additive Manufacturing 2.0 production technology
DM now has metal and ceramic parts in production in multiple high value programs in defense and aerospace with parts in several jet engine families, major platforms like F35 and in several space vehicles
Growing business in Gigacasting with several global automakers
Fourth Quarter 2023 Financial Highlights
Revenue of $52.3 million, down from $60.6 million in the same quarter a year ago, and up 22% sequentially over the prior quarter
GAAP gross margin of (32)%; GAAP gross margin was negatively impacted by restructuring activities in the quarter. Non-GAAP gross margin of 34%, a year-over-year increase of 39.9%.
GAAP net loss of $(174.5) million, including $110.5 million of goodwill impairment; non-GAAP net loss of $(10.9) million
Adjusted EBITDA of $(9.2) million, a year-over-year improvement of 56% – and the company’s strongest quarterly performance to date
Cash, cash equivalents, and short-term investments closed fourth quarter 2023 at $84.5 million, as rate of cash consumption declined 25% compared to the same year-ago quarter
Lots to look at here:
Product Performance
Desktop Metal and Evonik expand partnership, announce qualification of INFINAM® ST 6100 L on large format Additive Manufacturing 2.0 systems for high-performance, high-temperature products
Desktop Health™ announces Flexcera™ Base Ultra+ dental resin for stronger, more comfortable 3D Printed dentures
Desktop Metal now shipping the Figur G15 – a Digital Sheet Metal Forming machine that eliminates the need for custom tooling
Desktop Health announces first patients treated with FDA-Cleared CMFlex™ – and off-the-shelf 3D printed synthetic bone graft product pioneered by Dimension Inx on the 3D-Bioplotter®
Desktop Metal launches Live Monitor™ for users of Additive Manufacturing 2.0 production technology
DM now has metal and ceramic parts in production in multiple high value programs in defense and aerospace with parts in several jet engine families, major platforms like F35 and in several space vehicles
Growing business in Gigacasting with several global automakers
Fourth Quarter 2023 Financial Highlights
Revenue of $52.3 million, down from $60.6 million in the same quarter a year ago, and up 22% sequentially over the prior quarter
GAAP gross margin of (32)%; GAAP gross margin was negatively impacted by restructuring activities in the quarter. Non-GAAP gross margin of 34%, a year-over-year increase of 39.9%.
GAAP net loss of $(174.5) million, including $110.5 million of goodwill impairment; non-GAAP net loss of $(10.9) million
Adjusted EBITDA of $(9.2) million, a year-over-year improvement of 56% – and the company’s strongest quarterly performance to date
Cash, cash equivalents, and short-term investments closed fourth quarter 2023 at $84.5 million, as rate of cash consumption declined 25% compared to the same year-ago quarter
Is Missling expecting to have a bigger budget for payroll and R&D soon?
When you post a list like that you want to enclose it with the "pre" setting bottom left of the message box. It preserves the tab spacing and makes it easier to read.
Well shoot - I meant to make that private so this is my one post for the day:
Blocks >=1000
You will find end of day data here:
https://investorshub.advfn.com/Xenas-Study-Hall-29911
Link back to earlier data here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174021385
03/15/24 11:23:54 4.11 4.11 4.12 1,900
03/15/24 11:23:54 4.11 4.11 4.12 1,900
03/15/24 11:22:24 4.1109 4.11 4.12 3,000
03/15/24 11:19:59 4.1109 4.11 4.12 2,000
03/15/24 11:19:02 4.1109 4.11 4.12 1,600
03/15/24 11:13:46 4.1215 4.12 4.13 1,200
03/15/24 10:58:40 4.125 4.12 4.13 1,000
03/15/24 10:58:27 4.125 4.12 4.13 1,600
03/15/24 10:54:01 4.1303 4.13 4.14 4,000
03/15/24 10:49:43 4.13 4.12 4.13 2,000
03/15/24 10:29:35 4.095 4.09 4.10 1,000
03/15/24 10:18:43 4.115 4.11 4.12 1,000
03/15/24 10:18:01 4.1105 4.11 4.12 2,000
03/15/24 10:16:42 4.1173 4.11 4.12 1,000
03/15/24 10:14:12 4.10 4.09 4.10 2,400
03/15/24 10:10:25 4.07 4.07 4.08 2,000
03/15/24 10:10:22 4.07 4.07 4.08 2,000
03/15/24 10:08:41 4.065 4.06 4.07 1,000
03/15/24 10:07:02 4.05 4.04 4.05 1,000
03/15/24 10:07:02 4.05 4.04 4.05 1,300
03/15/24 10:05:07 4.06 4.05 4.06 1,300
03/15/24 09:59:26 4.05 4.03 4.05 4,000
03/15/24 09:56:16 4.045 4.04 4.05 2,000
03/15/24 09:53:29 4.035 4.03 4.04 1,200
03/15/24 09:49:16 4.02 4.02 4.03 1,395
03/15/24 09:48:48 4.0206 4.02 4.03 1,000
03/15/24 09:46:01 4.02 4.02 4.03 1,300
03/15/24 09:43:18 4.02 4.02 4.03 1,100
03/15/24 09:42:50 4.02 4.02 4.03 1,100
03/15/24 09:42:50 4.02 4.02 4.03 1,100
03/15/24 09:30:00 3.95 3.97 4.46 171,200
03/14/24 16:02:20 3.97 3.95 4.25 1,100
03/14/24 16:02:17 3.97 3.95 4.25 3,500
03/14/24 16:02:09 3.97 3.95 4.25 10,600
03/14/24 16:00:00 3.975 3.95 4.00 85,571
03/14/24 15:59:59 3.975 3.98 3.99 1,311
03/14/24 15:58:01 3.98 3.97 3.98 1,344
03/14/24 15:58:01 3.98 3.98 3.99 1,100
03/14/24 15:58:01 3.98 3.98 3.99 1,500
03/14/24 15:58:01 3.98 3.98 3.99 1,800
03/14/24 15:56:01 3.98 3.97 3.98 1,100
03/14/24 15:50:00 3.98 3.98 3.99 2,906
03/14/24 15:46:12 3.98 3.98 3.99 2,460
03/14/24 15:46:11 3.98 3.98 3.99 1,100
03/14/24 15:42:39 3.99 3.99 4.00 1,038
03/14/24 15:42:39 3.99 3.98 3.99 1,700
03/14/24 15:42:20 3.985 3.98 3.99 1,183
03/14/24 15:38:22 3.975 3.97 3.98 2,100
03/14/24 15:38:12 3.975 3.97 3.98 1,244
03/14/24 15:38:12 3.97 3.96 3.97 1,000
03/14/24 15:34:07 3.97 3.96 3.97 10,000
03/14/24 15:17:05 3.965 3.96 3.97 1,000
03/14/24 15:16:03 3.9599 3.95 3.96 2,500
03/14/24 15:11:04 3.9725 3.96 3.97 1,147
03/14/24 15:06:35 3.9803 3.98 3.99 1,000
03/14/24 15:05:29 3.9899 3.98 3.99 1,000
03/14/24 15:00:52 3.9991 3.99 4.00 1,000
03/14/24 14:59:52 3.9997 3.99 4.00 1,000
03/14/24 14:54:55 4.0001 4.00 4.01 2,200
03/14/24 14:50:01 4.00 4.00 4.01 1,100
03/14/24 14:40:29 3.98 3.98 3.99 1,047
03/14/24 14:37:35 3.985 3.98 3.99 5,000
03/14/24 14:30:32 3.995 3.99 4.00 5,000
03/14/24 14:30:28 3.9954 3.99 4.00 5,000
03/14/24 14:30:21 3.995 3.98 3.99 1,000
03/14/24 14:30:12 3.985 3.98 3.99 3,900
03/14/24 14:30:05 3.9848 3.98 3.99 3,200
03/14/24 14:30:05 3.99 3.98 3.99 1,400
03/14/24 14:28:34 3.9899 3.98 3.99 1,000
03/14/24 14:18:53 3.9807 3.98 3.99 3,100
03/14/24 13:47:52 3.9708 3.97 3.98 1,400
03/14/24 13:30:19 3.9692 3.96 3.97 1,500
03/14/24 13:17:05 3.955 3.95 3.96 1,107
03/14/24 13:17:05 3.955 3.95 3.96 1,400
03/14/24 13:17:05 3.95 3.95 3.96 2,400
03/14/24 13:17:05 3.95 3.95 3.96 2,000
03/14/24 13:13:59 3.96 3.96 3.97 7,100
03/14/24 13:07:09 3.985 3.98 3.99 1,400
03/14/24 12:59:17 3.9897 3.98 3.99 1,700
03/14/24 12:52:36 3.995 3.99 4.00 2,100
03/14/24 12:35:31 3.995 3.99 4.00 3,000
03/14/24 12:29:50 3.9985 3.99 4.00 1,200
03/14/24 12:15:15 3.978 3.97 3.98 2,600
03/14/24 12:13:49 3.985 3.98 3.99 1,500
03/14/24 12:13:49 3.985 3.98 3.99 1,300
03/14/24 12:13:49 3.985 3.98 3.99 1,000
03/14/24 12:13:24 3.985 3.98 3.99 1,600
03/14/24 12:13:24 3.985 3.98 3.99 1,500
03/14/24 12:13:24 3.985 3.98 3.99 1,300
03/14/24 12:09:57 3.985 3.98 3.99 3,300
03/14/24 12:09:57 3.985 3.98 3.99 1,100
03/14/24 12:08:30 3.985 3.98 3.99 2,400
03/14/24 12:08:30 3.985 3.98 3.99 1,200
03/14/24 12:08:30 3.985 3.98 3.99 3,100
03/14/24 12:08:30 3.985 3.98 3.99 3,200
03/14/24 12:07:28 3.9807 3.98 3.99 1,000
03/14/24 12:05:06 3.99 3.98 3.99 1,115
03/14/24 12:05:06 3.99 3.99 4.00 1,200
03/14/24 12:03:00 3.9923 3.99 4.00 1,700
03/14/24 12:02:55 3.9923 3.99 4.00 1,400
03/14/24 12:02:44 3.9915 3.99 4.00 3,000
03/14/24 11:59:10 4.005 4.00 4.01 10,000
03/14/24 11:58:25 4.0092 4.00 4.01 1,900
03/14/24 11:55:31 4.00 4.00 4.01 1,495
03/14/24 11:55:31 4.00 4.00 4.01 1,000
03/14/24 11:54:20 4.045 4.04 4.05 7,900
03/14/24 11:48:15 4.045 4.04 4.05 1,913
03/14/24 11:47:37 4.05 4.05 4.06 3,100
03/14/24 11:47:37 4.052 4.05 4.06 5,200
03/14/24 11:38:50 4.055 4.05 4.06 1,117
03/14/24 11:17:40 4.06 4.06 4.07 1,500
03/14/24 11:14:01 4.0612 4.06 4.07 1,000
03/14/24 11:05:40 4.06 4.05 4.06 1,300
03/14/24 10:48:58 4.0507 4.05 4.06 1,100
03/14/24 10:48:58 4.0507 4.05 4.06 1,300
03/14/24 10:44:47 4.065 4.06 4.07 1,000
03/14/24 10:33:30 4.05 4.04 4.05 3,700
03/14/24 10:17:25 4.02 4.02 4.03 2,000
03/14/24 10:16:30 4.02 4.02 4.03 1,700
03/14/24 10:10:18 4.015 4.01 4.02 1,310
03/14/24 10:10:18 4.005 4.01 4.02 1,500
03/14/24 10:10:18 4.00 4.01 4.02 8,100
03/14/24 10:10:18 4.00 4.01 4.02 1,900
03/14/24 10:06:08 4.025 4.02 4.03 5,000
03/14/24 10:05:28 4.03 4.03 4.04 3,600
03/14/24 10:05:28 4.03 4.03 4.04 1,300
03/14/24 10:05:21 4.03 4.04 4.05 2,900
03/14/24 10:04:54 4.0322 4.02 4.03 2,400
03/14/24 10:01:45 4.002 4.00 4.01 1,800
03/14/24 10:01:38 4.005 4.00 4.01 1,500
03/14/24 10:00:59 4.005 4.00 4.01 1,000
03/14/24 10:00:14 4.01 4.01 4.02 4,800
03/14/24 09:56:50 4.05 4.04 4.05 1,200
03/14/24 09:55:24 4.0623 4.06 4.07 1,400
03/14/24 09:53:04 4.065 4.06 4.07 1,000
03/14/24 09:52:13 4.07 4.06 4.07 1,000
03/14/24 09:48:57 4.09 4.09 4.10 1,000
03/14/24 09:48:53 4.10 4.09 4.10 4,300
03/14/24 09:48:53 4.10 4.10 4.11 1,000
03/14/24 09:47:56 4.11 4.10 4.11 1,700
03/14/24 09:47:36 4.10 4.09 4.10 1,200
03/14/24 09:47:23 4.09 4.09 4.10 1,300
03/14/24 09:47:22 4.10 4.10 4.11 1,300
03/14/24 09:47:19 4.11 4.11 4.12 1,000
03/14/24 09:47:19 4.11 4.11 4.12 1,000
03/14/24 09:47:16 4.11 4.10 4.11 1,000
03/14/24 09:47:16 4.11 4.10 4.11 1,100
03/14/24 09:47:06 4.11 4.11 4.12 1,700
03/14/24 09:47:06 4.11 4.11 4.12 1,300
03/14/24 09:46:16 4.11 4.11 4.12 1,300
03/14/24 09:40:25 4.12 4.12 4.13 3,900
03/14/24 09:40:25 4.12 4.12 4.13 1,000
03/14/24 09:38:02 4.1311 4.13 4.14 2,000
03/14/24 09:37:59 4.1311 4.13 4.14 2,000
03/14/24 09:36:24 4.125 4.12 4.13 1,000
03/14/24 09:33:55 4.09 4.09 4.11 1,500
03/14/24 09:33:22 4.10 4.09 4.11 1,434
03/14/24 09:33:22 4.10 4.10 4.14 1,000
03/14/24 09:30:05 4.15 4.11 4.17 2,500
03/14/24 09:30:00 4.10 4.09 4.36 5,100
03/13/24 16:02:22 4.12 4.01 4.36 1,400
03/13/24 16:02:03 4.12 4.01 4.36 1,200
03/13/24 16:01:57 4.12 4.01 4.36 2,800
03/13/24 16:01:38 4.12 4.01 4.36 2,600
03/13/24 16:01:36 4.12 4.01 4.36 1,000
03/13/24 16:00:00 4.12 4.11 4.13 68,461
03/13/24 15:59:59 4.12 4.12 4.13 6,399
03/13/24 15:59:57 4.12 4.12 4.13 3,509
03/13/24 15:59:56 4.12 4.11 4.12 2,597
03/13/24 15:59:02 4.1199 4.11 4.12 5,000
03/13/24 15:58:37 4.1198 4.11 4.12 5,000
03/13/24 15:53:21 4.12 4.11 4.12 1,644
03/13/24 15:52:52 4.119 4.11 4.12 3,900
03/13/24 15:52:40 4.115 4.11 4.12 1,800
03/13/24 15:50:11 4.115 4.11 4.12 1,551
03/13/24 15:50:11 4.11 4.11 4.12 3,000
03/13/24 15:45:47 4.115 4.11 4.12 5,000
03/13/24 15:44:43 4.1117 4.11 4.12 1,500
03/13/24 15:31:31 4.125 4.12 4.13 1,000
03/13/24 15:08:26 4.135 4.13 4.14 1,000
03/13/24 15:07:44 4.15 4.15 4.16 1,000
03/13/24 15:07:44 4.15 4.15 4.16 1,904
03/13/24 14:42:33 4.205 4.20 4.21 1,526
03/13/24 14:33:22 4.205 4.20 4.21 1,000
03/13/24 14:10:06 4.205 4.19 4.20 1,381
03/13/24 13:47:10 4.205 4.20 4.21 1,500
03/13/24 13:35:11 4.20 4.20 4.21 1,000
03/13/24 12:20:09 4.2101 4.21 4.22 2,000
03/13/24 12:17:14 4.2212 4.22 4.23 1,400
03/13/24 12:17:08 4.22 4.22 4.23 3,000
03/13/24 11:36:26 4.221 4.22 4.23 3,900
03/13/24 11:35:55 4.219 4.21 4.22 3,900
03/13/24 11:16:39 4.215 4.21 4.22 1,000
03/13/24 11:00:57 4.20 4.20 4.21 3,100
03/13/24 10:49:21 4.2009 4.20 4.21 1,000
03/13/24 10:32:20 4.22 4.25 4.26 5,200
03/13/24 10:21:44 4.265 4.26 4.27 1,000
03/13/24 10:12:34 4.28 4.27 4.28 2,300
03/13/24 09:36:31 4.23 4.22 4.23 2,900
03/13/24 09:30:01 4.16 4.15 4.18 2,416
03/13/24 09:30:00 4.16 4.08 4.18 1,700
03/12/24 16:02:49 4.19 4.00 4.40 1,100
03/12/24 16:01:50 4.19 4.00 4.40 3,800
03/12/24 16:01:34 4.19 4.00 4.40 16,100
03/12/24 16:00:00 4.20 4.18 4.21 66,181
03/12/24 15:57:58 4.21 4.20 4.21 1,200
03/12/24 15:55:30 4.205 4.20 4.21 1,200
03/12/24 15:54:40 4.215 4.20 4.21 10,274
03/12/24 15:51:36 4.21 4.21 4.22 1,153
03/12/24 15:51:06 4.199 4.19 4.20 1,099
03/12/24 15:40:15 4.2092 4.20 4.21 2,100
03/12/24 15:40:13 4.2001 4.20 4.21 5,000
03/12/24 15:26:53 4.206 4.20 4.21 5,000
03/12/24 15:17:01 4.2008 4.20 4.21 1,000
03/12/24 15:07:03 4.20 4.20 4.21 1,363
03/12/24 15:06:53 4.2018 4.20 4.21 3,900
03/12/24 15:06:15 4.19 4.16 4.17 3,100
03/12/24 14:52:40 4.175 4.17 4.18 1,500
03/12/24 14:43:35 4.165 4.17 4.18 1,667
03/12/24 14:38:39 4.16 4.17 4.18 1,000
03/12/24 14:38:39 4.16 4.17 4.18 1,000
03/12/24 14:06:12 4.19 4.17 4.18 5,700
03/12/24 14:06:12 4.19 4.17 4.18 1,400
03/12/24 14:06:12 4.19 4.17 4.18 2,800
03/12/24 14:00:16 4.1712 4.17 4.18 2,600
03/12/24 13:59:22 4.1917 4.19 4.20 3,000
03/12/24 13:57:16 4.20 4.19 4.20 1,200
03/12/24 13:56:46 4.20 4.19 4.20 1,300
03/12/24 13:39:26 4.21 4.21 4.22 4,000
03/12/24 13:34:03 4.2101 4.21 4.22 4,000
03/12/24 13:34:03 4.21 4.21 4.22 1,000
03/12/24 13:12:46 4.20 4.21 4.22 1,100
03/12/24 13:12:46 4.20 4.21 4.22 1,400
03/12/24 13:12:46 4.20 4.21 4.22 1,400
03/12/24 13:12:29 4.2101 4.21 4.22 5,000
03/12/24 13:11:45 4.2112 4.21 4.22 1,400
03/12/24 13:11:45 4.21 4.21 4.22 1,400
03/12/24 13:11:45 4.2112 4.21 4.22 2,800
03/12/24 13:02:00 4.21 4.21 4.22 1,300
03/12/24 12:45:26 4.21 4.20 4.21 1,400
03/12/24 12:45:26 4.21 4.20 4.21 1,300
03/12/24 12:45:26 4.2162 4.20 4.21 1,364
03/12/24 12:45:26 4.2162 4.20 4.21 3,566
03/12/24 12:43:12 4.2162 4.21 4.22 1,000
03/12/24 12:42:40 4.21 4.21 4.22 1,000
03/12/24 12:29:42 4.2101 4.21 4.22 3,000
03/12/24 12:19:01 4.21 4.21 4.22 1,000
03/12/24 12:19:01 4.21 4.21 4.22 1,300
03/12/24 11:46:59 4.21 4.21 4.22 1,200
03/12/24 11:46:59 4.21 4.21 4.22 1,200
03/12/24 11:41:40 4.21 4.21 4.22 1,100
03/12/24 11:40:54 4.21 4.21 4.21 1,100
03/12/24 11:40:29 4.21 4.21 4.22 1,300
03/12/24 11:35:34 4.21 4.20 4.21 1,200
03/12/24 11:35:34 4.21 4.20 4.21 1,000
03/12/24 11:33:21 4.2101 4.21 4.22 4,100
03/12/24 11:32:39 4.21 4.21 4.22 1,400
03/12/24 11:24:26 4.20 4.20 4.21 1,054
03/12/24 11:24:11 4.20 4.20 4.21 4,900
03/12/24 11:22:38 4.22 4.22 4.23 3,100
03/12/24 11:21:36 4.2218 4.22 4.23 2,600
03/12/24 11:10:01 4.2101 4.21 4.22 1,000
03/12/24 10:54:01 4.2101 4.21 4.22 1,000
03/12/24 10:20:32 4.1989 4.19 4.20 1,000
03/12/24 10:06:45 4.2178 4.21 4.22 1,000
03/12/24 10:05:21 4.21 4.22 4.23 2,200
03/12/24 10:05:20 4.21 4.22 4.23 2,400
03/12/24 10:05:05 4.22 4.22 4.23 2,000
03/12/24 09:47:20 4.17 4.16 4.17 1,100
03/12/24 09:47:02 4.17 4.17 4.18 1,400
03/12/24 09:46:54 4.18 4.19 4.20 2,600
03/12/24 09:46:28 4.1783 4.16 4.17 2,900
03/12/24 09:44:41 4.17 4.16 4.17 1,000
03/12/24 09:44:41 4.1699 4.16 4.17 1,400
03/12/24 09:43:05 4.16 4.16 4.17 1,100
03/12/24 09:43:05 4.16 4.16 4.17 1,100
03/12/24 09:38:30 4.16 4.17 4.18 1,200
03/12/24 09:30:26 4.21 4.20 4.23 1,000
03/12/24 09:30:00 4.21 4.11 4.50 1,800
There is no way this is "organic" trading...
03/15/24 09:35:23 4.01 4.01 4.02 100
03/15/24 09:35:10 4.02 4.01 4.02 63
03/15/24 09:35:07 4.02 4.02 4.03 6
03/15/24 09:35:05 4.02 4.02 4.03 210
03/15/24 09:35:05 4.02 4.03 4.04 100
03/15/24 09:35:03 4.04 4.04 4.05 100
03/15/24 09:35:03 4.04 4.04 4.05 100
03/15/24 09:35:03 4.04 4.04 4.05 200
03/15/24 09:35:02 4.04 4.02 4.03 100
03/15/24 09:35:02 4.04 4.02 4.03 100
03/15/24 09:35:02 4.04 4.02 4.03 200
03/15/24 09:35:02 4.04 4.02 4.03 100
03/15/24 09:35:02 4.04 4.02 4.03 200
03/15/24 09:35:02 4.04 4.02 4.03 100
03/15/24 09:35:02 4.04 4.02 4.03 100
03/15/24 09:35:02 4.04 4.02 4.03 100
03/15/24 09:35:01 4.03 4.02 4.03 215
03/15/24 09:35:01 4.03 3.98 4.01 100
03/15/24 09:35:01 4.02 3.98 4.01 100
03/15/24 09:35:01 4.02 3.98 4.01 100
03/15/24 09:35:01 4.02 3.98 4.01 100
03/15/24 09:35:01 4.02 3.98 4.01 100
03/15/24 09:35:01 4.02 3.98 4.01 100
03/15/24 09:35:01 3.99 3.98 4.01 100
03/15/24 09:35:01 4.00 3.98 4.01 100
03/15/24 09:35:01 4.00 3.98 4.01 100
03/15/24 09:35:01 3.995 3.98 4.01 100
03/15/24 09:35:01 3.995 3.98 4.01 100
03/15/24 09:34:33 3.99 3.97 4.01 100
03/15/24 09:33:04 3.9919 3.97 4.01 1
03/15/24 09:33:04 3.9919 3.97 4.01 30
03/15/24 09:33:04 3.9919 3.97 4.01 100
03/15/24 09:32:59 3.985 3.97 4.01 92
03/15/24 09:32:32 3.985 3.96 4.01 32
03/15/24 09:32:09 3.985 3.96 4.00 1
03/15/24 09:31:55 3.985 3.96 4.00 20
03/15/24 09:31:17 3.985 3.96 4.02 10
03/15/24 09:31:15 3.985 3.95 4.04 100
03/15/24 09:30:02 3.95 3.95 4.05 1
03/15/24 09:30:00 3.95 3.95 4.10 226
03/15/24 09:30:00 3.95 3.97 4.46 171,200
03/15/24 09:30:00 3.95 3.97 4.46 200
03/15/24 09:30:00 3.95 3.97 4.46 100
03/15/24 09:30:00 3.95 3.97 4.46 500
03/15/24 09:30:00 3.97 3.97 4.46 100
03/15/24 09:30:00 3.97 3.97 4.46 100
03/15/24 09:30:00 3.97 3.97 4.46 100
03/15/24 09:22:06 4.10 3.95 4.50 3
03/15/24 08:30:40 4.00 3.95 4.50 50
03/15/24 08:30:27 4.00 3.95 4.50 50
I disagree with this statement:
It is extremely clear that the markets viewed the EXCELLENCE trial as a failure. That is the bottom line and all the word salads in the world won't erase the resultant 35% drop in AVXL's stock price. Sometimes a 30,000 foot view will add clarity. It's really not necessary to stomp around in the weeds.
I disagree with this statement:
It is extremely clear that the markets viewed the EXCELLENCE trial as a failure. That is the bottom line and all the word salads in the world won't erase the resultant 35% drop in AVXL's stock price. Sometimes a 30,000 foot view will add clarity. It's really not necessary to stomp around in the weeds.
My read on this is that BONAR is getting ready to take the DFCO shell private....
.... AGAIN....
Please note that a share reduction is not a share buyback.
Company reduces authorized shares and satisfies debt, cleaning up capitalization to lay the groundwork for anticipated growth and future success.
SAN DIEGO, CA / ACCESSWIRE / March 14, 2024 / Dalrada Financial Corporation (OTCQB:DFCO), ("Dalrada," "the Company"), announced today that it had filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC), highlighting the Company's decision to reduce its number of authorized common shares from 1 billion to 500 million.
The share reduction announcement comes just weeks after Dalrada filed another 8-K in which CEO and Founder, Brian Bonar, addressed shareholders about the major events of the past year, setting up the Company's ambitious goals for 2024 and beyond-particularly within the climate technology and healthcare sectors.
"I'm pleased to say that we've been able to form a solid foundation for Dalrada's progress and future success," according to Bonar. "Our intention is to expand upon our company wins in multiple business markets and keep that momentum going," he added.
In addition to the overall share reduction, the Company successfully converted a total of approximately $34 million in related party debt to preferred stock during fiscal year ending 2023.
Dalrada's authorized common share reduction and debt conversion to preferred stock show the Company's commitment to improving value for every shareholder while signaling the strength of its subsidiaries and core product offerings.